Medical Properties Trust (MPW) 10-Q 8 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 06, 2013
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'MPW	'
Entity Registrant Name	'MEDICAL PROPERTIES TRUST INC.	'
Entity Central Index Key	'0001287865	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	161,571,911
MPT Operating Partnership, L.P.	'	'
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'MPT Operating Partnership, L.P.	'
Entity Central Index Key	'0001524607	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Non-accelerated Filer	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Real estate assets	'	'
Land, buildings and improvements, and intangible lease assets	$1,606,432	$1,262,099
Real estate held for sale	'	16,497
Mortgage loans	368,650	368,650
Net investment in direct financing leases	403,512	314,412
Gross investment in real estate assets	2,378,594	1,961,658
Accumulated depreciation and amortization	-150,666	-124,615
Net investment in real estate assets	2,227,928	1,837,043
Cash and cash equivalents	12,124	37,311
Interest and rent receivable	54,505	45,289
Straight-line rent receivable	44,240	35,860
Other loans	161,245	159,243
Other assets	63,108	64,140
Total Assets	2,563,150	2,178,886
Liabilities	'	'
Debt, net	1,086,973	1,025,160
Accounts payable and accrued expenses	73,852	65,961
Deferred revenue	23,229	20,609
Lease deposits and other obligations to tenants	20,527	17,342
Total liabilities	1,204,581	1,129,072
Capital	'	'
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding	'	'
Common stock, $0.001 par value. Authorized 250,000 shares; issued and outstanding - 160,880 shares at September 30, 2013 and 136,335 shares at December 31, 2012	160	136
Additional paid in capital	1,615,230	1,295,916
Distributions in excess of net income	-246,865	-233,494
Accumulated other comprehensive loss	-9,694	-12,482
Treasury shares, at cost	-262	-262
Total Equity	1,358,569	1,049,814
Total Liabilities and Equity	2,563,150	2,178,886
Limited Partners:	'	'
Accumulated other comprehensive loss	-9,694	-12,482
Total Equity	1,358,569	1,049,814
Total Liabilities and Equity	2,563,150	2,178,886
MPT Operating Partnership, L.P.	'	'
Real estate assets	'	'
Land, buildings and improvements, and intangible lease assets	1,606,432	1,262,099
Real estate held for sale	'	16,497
Mortgage loans	368,650	368,650
Net investment in direct financing leases	403,512	314,412
Gross investment in real estate assets	2,378,594	1,961,658
Accumulated depreciation and amortization	-150,666	-124,615
Net investment in real estate assets	2,227,928	1,837,043
Cash and cash equivalents	12,124	37,311
Interest and rent receivable	54,505	45,289
Straight-line rent receivable	44,240	35,860
Other loans	161,245	159,243
Other assets	63,108	64,140
Total Assets	2,563,150	2,178,886
Liabilities	'	'
Debt, net	1,086,973	1,025,160
Accounts payable and accrued expenses	41,409	38,177
Deferred revenue	23,229	20,609
Lease deposits and other obligations to tenants	20,527	17,342
Payable due to Medical Properties Trust, Inc.	32,053	27,394
Total liabilities	1,204,191	1,128,682
Capital	'	'
Accumulated other comprehensive loss	-9,694	-12,482
Total Equity	1,358,959	1,050,204
Total Liabilities and Equity	2,563,150	2,178,886
Limited Partners:	'	'
Accumulated other comprehensive loss	-9,694	-12,482
Total Equity	1,358,959	1,050,204
Total Liabilities and Equity	2,563,150	2,178,886
MPT Operating Partnership, L.P. | General Partner	'	'
Capital	'	'
General Partner - issued and outstanding - 1,603 units at September 30, 2013 and 1,357 units at December 31, 2012	13,692	10,630
MPT Operating Partnership, L.P. | Common Units	'	'
Limited Partners:	'	'
Limited Partners Capital Account	1,354,961	1,052,056
MPT Operating Partnership, L.P. | LTIP Units	'	'
Limited Partners:	'	'
Limited Partners Capital Account	'	'

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012
			General Partner	General Partner	Common Units	Common Units	LTIP Units	LTIP Units
			MPT Operating Partnership, L.P.	MPT Operating Partnership, L.P.	MPT Operating Partnership, L.P.	MPT Operating Partnership, L.P.	MPT Operating Partnership, L.P.	MPT Operating Partnership, L.P.
Preferred stock, par value	$0.00	$0.00	'	'	'	'	'	'
Preferred stock, shares authorized	10,000,000	10,000,000	'	'	'	'	'	'
Preferred stock, shares outstanding	'	'	'	'	'	'	'	'
Common stock, par value	$0.00	$0.00	'	'	'	'	'	'
Common stock, shares authorized	250,000,000	250,000,000	'	'	'	'	'	'
Common stock, shares issued	160,880,000	136,335,000	'	'	'	'	'	'
Common stock, shares outstanding	160,880,000	136,335,000	'	'	'	'	'	'
General partner, units issued	'	'	1,603,000	1,357,000	'	'	'	'
General partner, units outstanding	'	'	1,603,000	1,357,000	'	'	'	'
Limited Partners, units issued	'	'	'	'	159,277,000	134,978,000	'	'
Limited Partners, units outstanding	'	'	'	'	159,277,000	134,978,000	'	'
LTIP Units, shares issued	'	'	'	'	'	'	221,000	221,000
LTIP Units, shares outstanding	'	'	'	'	'	'	221,000	221,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues	'	'	'	'
Rent billed	$31,878	$30,298	$95,074	$90,680
Straight-line rent	2,853	2,745	8,260	5,429
Income from direct financing leases	11,298	5,773	29,284	12,979
Interest and fee income	14,427	14,037	43,282	33,486
Total revenues	60,456	52,853	175,900	142,574
Expenses	'	'	'	'
Real estate depreciation and amortization	8,789	8,308	26,051	24,826
Property-related	458	214	1,520	1,027
General and administrative	6,380	7,052	21,423	21,341
Acquisition expenses	4,179	410	6,457	4,115
Total operating expenses	19,806	15,984	55,451	51,309
Operating income	40,650	36,869	120,449	91,265
Other income (expense)	'	'	'	'
Interest and other income (expense)	3	-23	-245	-55
Earnings from equity and other interests	843	1,065	2,511	1,944
Interest expense	-15,830	-15,046	-45,896	-42,730
Net other expense	-14,984	-14,004	-43,630	-40,841
Income from continuing operations	25,666	22,865	76,819	50,424
Income from discontinued operations	37	8,643	2,498	11,050
Net income	25,703	31,508	79,317	61,474
Net income attributable to non-controlling interests	-55	-44	-165	-130
Net income attributable to MPT common stockholders	25,648	31,464	79,152	61,344
Earnings per common share - basic	'	'	'	'
Income from continuing operations attributable to MPT common stockholders	$0.16	$0.17	$0.51	$0.38
Income from discontinued operations attributable to MPT common stockholders	'	$0.06	$0.02	$0.08
Net income attributable to MPT common stockholders	$0.16	$0.23	$0.53	$0.46
Earnings per common share - diluted	'	'	'	'
Income from continuing operations attributable to MPT common stockholders	$0.16	$0.17	$0.51	$0.38
Income from discontinued operations attributable to MPT common stockholders	'	$0.06	$0.02	$0.08
Net income attributable to MPT common stockholders	$0.16	$0.23	$0.53	$0.46
Weighted average shares outstanding:	'	'	'	'
Basic	154,758	134,781	148,204	131,467
Diluted	155,969	134,782	149,517	131,467
Dividends declared per common share	$0.20	$0.20	$0.60	$0.60
MPT Operating Partnership, L.P.	'	'	'	'
Revenues	'	'	'	'
Rent billed	31,878	30,298	95,074	90,680
Straight-line rent	2,853	2,745	8,260	5,429
Income from direct financing leases	11,298	5,773	29,284	12,979
Interest and fee income	14,427	14,037	43,282	33,486
Total revenues	60,456	52,853	175,900	142,574
Expenses	'	'	'	'
Real estate depreciation and amortization	8,789	8,308	26,051	24,826
Property-related	458	214	1,520	1,027
General and administrative	6,380	7,052	21,423	21,341
Acquisition expenses	4,179	410	6,457	4,115
Total operating expenses	19,806	15,984	55,451	51,309
Operating income	40,650	36,869	120,449	91,265
Other income (expense)	'	'	'	'
Interest and other income (expense)	3	-23	-245	-55
Earnings from equity and other interests	843	1,065	2,511	1,944
Interest expense	-15,830	-15,046	-45,896	-42,730
Net other expense	-14,984	-14,004	-43,630	-40,841
Income from continuing operations	25,666	22,865	76,819	50,424
Income from discontinued operations	37	8,643	2,498	11,050
Net income	25,703	31,508	79,317	61,474
Net income attributable to non-controlling interests	-55	-44	-165	-130
Net income attributable to MPT common stockholders	$25,648	$31,464	$79,152	$61,344
Earnings per common share - basic	'	'	'	'
Income from continuing operations attributable to MPT common stockholders	$0.16	$0.17	$0.51	$0.38
Income from discontinued operations attributable to MPT common stockholders	'	$0.06	$0.02	$0.08
Net income attributable to MPT common stockholders	$0.16	$0.23	$0.53	$0.46
Earnings per common share - diluted	'	'	'	'
Income from continuing operations attributable to MPT common stockholders	$0.16	$0.17	$0.51	$0.38
Income from discontinued operations attributable to MPT common stockholders	'	$0.06	$0.02	$0.08
Net income attributable to MPT common stockholders	$0.16	$0.23	$0.53	$0.46
Weighted average shares outstanding:	'	'	'	'
Basic	154,758	134,781	148,204	131,467
Diluted	155,969	134,782	149,517	131,467
Dividends declared per common share	$0.20	$0.20	$0.60	$0.60

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Loss) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net income	$25,703	$31,508	$79,317	$61,474
Other comprehensive income (loss):	'	'	'	'
Unrealized gain (loss) on interest rate swap	182	-443	2,788	-989
Total comprehensive income (loss)	25,885	31,065	82,105	60,485
Comprehensive income attributable to non-controlling interests	-55	-44	-165	-130
Comprehensive income (loss) attributable to MPT common stockholders	25,830	31,021	81,940	60,355
MPT Operating Partnership, L.P.	'	'	'	'
Net income	25,703	31,508	79,317	61,474
Other comprehensive income (loss):	'	'	'	'
Unrealized gain (loss) on interest rate swap	182	-443	2,788	-989
Total comprehensive income (loss)	25,885	31,065	82,105	60,485
Comprehensive income attributable to non-controlling interests	-55	-44	-165	-130
Comprehensive income (loss) attributable to MPT common stockholders	$25,830	$31,021	$81,940	$60,355

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flow (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating Activities	'	'
Net income	$79,317	$61,474
Adjustments to reconcile net income to net cash provided by operating activities	'	'
Depreciation and amortization	27,000	26,899
Straight-line rent revenue	-8,260	-5,429
Direct financing lease interest accretion	-4,106	-2,050
Share-based compensation	6,019	5,430
Gain on sale of real estate	-2,054	-7,278
Amortization and write-off of deferred financing costs and debt discount	2,624	2,577
Other adjustments	4,156	-3,415
Changes in:	'	'
Interest and rent receivable	-9,216	-12,232
Accounts payable and accrued expenses	6,084	7,404
Net cash provided by operating activities	101,564	74,709
Investing activities	'	'
Cash paid for acquisitions and other related investments	-371,500	-606,500
Principal received on loans receivable	4,694	9,507
Net proceeds from sale of real estate	18,409	34,100
Investment in loans receivable	-1,445	-1,293
Construction in progress and other	-63,422	-35,920
Net cash provided by (used in) investing activities	-413,264	-600,106
Financing Activities	'	'
Revolving credit facilities, net	-80,000	35,400
Additions to term debt	153,000	300,000
Payments of term debt	-11,185	-171
Distributions paid	-87,928	-76,770
Proceeds from sale of common shares, net of offering costs	313,319	220,107
Lease deposits and other obligations to tenants	3,589	-13,391
Debt issuance costs paid and other financing activities	-4,282	-6,341
Net cash provided by financing activities	286,513	458,834
Decrease in cash and cash equivalents for period	-25,187	-66,563
Cash and cash equivalents at beginning of period	37,311	102,726
Cash and cash equivalents at end of period	12,124	36,163
Interest paid	38,997	31,350
Supplemental schedule of non-cash investing activities:	'	'
Loan conversion to equity interest	'	1,648
Supplemental schedule of non-cash financing activities:	'	'
Distributions declared, unpaid	32,381	27,181
MPT Operating Partnership, L.P.	'	'
Operating Activities	'	'
Net income	79,317	61,474
Adjustments to reconcile net income to net cash provided by operating activities	'	'
Depreciation and amortization	27,000	26,899
Straight-line rent revenue	-8,260	-5,429
Direct financing lease interest accretion	-4,106	-2,050
Share-based compensation	6,019	5,430
Gain on sale of real estate	-2,054	-7,278
Amortization and write-off of deferred financing costs and debt discount	2,624	2,577
Other adjustments	4,156	-3,415
Changes in:	'	'
Interest and rent receivable	-9,216	-12,232
Accounts payable and accrued expenses	6,084	7,404
Net cash provided by operating activities	101,564	74,709
Investing activities	'	'
Cash paid for acquisitions and other related investments	-371,500	-606,500
Principal received on loans receivable	4,694	9,507
Net proceeds from sale of real estate	18,409	34,100
Investment in loans receivable	-1,445	-1,293
Construction in progress and other	-63,422	-35,920
Net cash provided by (used in) investing activities	-413,264	-600,106
Financing Activities	'	'
Revolving credit facilities, net	-80,000	35,400
Additions to term debt	153,000	300,000
Payments of term debt	-11,185	-171
Distributions paid	-87,928	-76,770
Proceeds from sale of common shares, net of offering costs	313,319	220,107
Lease deposits and other obligations to tenants	3,589	-13,391
Debt issuance costs paid and other financing activities	-4,282	-6,341
Net cash provided by financing activities	286,513	458,834
Decrease in cash and cash equivalents for period	-25,187	-66,563
Cash and cash equivalents at beginning of period	37,311	102,726
Cash and cash equivalents at end of period	12,124	36,163
Interest paid	38,997	31,350
Supplemental schedule of non-cash investing activities:	'	'
Loan conversion to equity interest	'	1,648
Supplemental schedule of non-cash financing activities:	'	'
Distributions declared, unpaid	$32,381	$27,181

Organization

Organization	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Organization	'
	1. Organization
	Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., (the “Operating Partnership”) through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist.
	We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRSs”). Our TRSs are subject to both U.S. federal and state income taxes.
	Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment. All of our properties are currently located in the United States; however, we have committed to acquire the RHM Portfolio (as more fully described in Note 10) which will represent our first acquisition (if consummated) outside of the United States.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	2. Summary of Significant Accounting Policies
	Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended September 30, 2013, are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. The condensed consolidated balance sheet at December 31, 2012 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.
	For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2012. During the nine months ended September 30, 2013, there were no material changes to these policies.
	Reclassifications: Certain reclassifications have been made to the condensed consolidated financial statements to conform to the 2013 consolidated financial statement presentation. These reclassifications had no impact on stockholders’ equity or net income.
	Variable Interest Entities
	At September 30, 2013, we had loans to and/or equity investments in several variable interest entities (“VIEs”) for which we are not the primary beneficiary. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2013 (in thousands):
	VIE Type		Maximum Loss		Asset Type	Carrying
			Exposure(1)		Classification	Amount(2)
	Loans, net		$	283,157	Mortgage and other loans	$	229,646
	Equity investments		$	19,519	Other assets	$	5,079
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rent receivables), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
	For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrower or investee) that most significantly impact the VIE’s economic performance. As of September 30, 2013, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).
	Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.
	See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Real_Estate_and_Lending_Activi

Real Estate and Lending Activities	9 Months Ended
	Sep. 30, 2013
Leases [Abstract]	'
Real Estate and Lending Activities	'
	3. Real Estate and Lending Activities
	Acquisitions
	2013 Activity
	On September 26, 2013, we acquired three general acute care hospitals from affiliates of IASIS Healthcare LLC (“IASIS”) for a combined purchase price of $283.3 million (including a commitment to provide approximately $2.0 million for improvements to a fourth hospital that we already own). Each of the facilities will be leased back to IASIS under leases with initial 15-year terms plus two renewal options of five years each, and consumer price-indexed rent increases limited to a 2.5% ceiling annually. The lessees will also have a right of first refusal option with respect to subsequent proposed sales of the facilities. All of our leases with affiliates of IASIS will be cross-defaulted with each other. In addition to the IASIS acquisitions transactions, we have amended our lease with IASIS for the Pioneer Valley Hospital in West Valley City, Utah, which extended the lease to 2028 from 2019 and adjusted the rent.
	On July 18, 2013, we acquired the real estate of Esplanade Rehab Hospital in Corpus Christi, Texas (now operating as Corpus Christi Rehabilitation Hospital) for $15.8 million (including a $0.5 million commitment to acquire adjacent land and leased the facility to an affiliate of Ernest Health Inc. (“Ernest”) under the master lease agreement entered into with Ernest in 2012 that initially provided for a 20-year term with three five-year extension options, plus consumer price-indexed rent increases, limited to a 2% floor and 5% ceiling annually.
	On June 11, 2013, we acquired the real estate of two acute care hospitals in Kansas from affiliates of Prime Healthcare Services, Inc. (“Prime”) for a combined purchase price of $75 million and leased the facilities to the operator under a master lease agreement. The master lease is for 10 years and contains two renewal options of five years each, and the rent increases annually based on the greater of the consumer price-index or 2%. This lease is accounted for as a direct financing lease (“DFL”).
	2012 Activity
	On September 19, 2012, we acquired the real estate of the 380 bed St. Mary’s Regional Medical Center, an acute care hospital in Reno, Nevada for $80 million and the real estate of the 140 bed Roxborough Memorial Hospital in Pennsylvania for $30 million. The acquired facilities are leased to Prime pursuant to a master lease agreement.
	On July 3, 2012, we funded a $100 million mortgage loan secured by the real property of Centinela Hospital Medical Center. Centinela is a 369 bed acute care facility that is operated by Prime. This mortgage loan is cross-defaulted with other mortgage loans to Prime and the master lease agreements.
	On February 29, 2012, we made loans to and acquired assets from Ernest for a combined purchase price and investment of $396.5 million (“Ernest Transaction”).
	Real Estate Acquisition and Mortgage Loan Financing
	Pursuant to a definitive real property asset purchase agreement, we acquired from Ernest and certain of its subsidiaries (i) a portfolio of five rehabilitation facilities (including a ground lease interest relating to a community-based acute rehabilitation facility in Wyoming), (ii) seven long-term acute care facilities located in seven states and (iii) undeveloped land in Provo, Utah (collectively, the “Acquired Facilities”) for an aggregate purchase price of $200 million, subject to certain adjustments. The Acquired Facilities are leased to subsidiaries of Ernest pursuant to a master lease agreement. The master lease agreement has a 20-year term with three five-year extension options and provided for an initial rental rate of 9%, with consumer price-indexed increases, limited to a 2% floor and 5% ceiling annually thereafter. In addition, we made Ernest a $100 million loan secured by a first mortgage interest in four subsidiaries of Ernest, which has terms similar to the leasing terms described above.
	Acquisition Loan and Equity Contribution
	Through an affiliate of one of our TRSs, we made investments of approximately $96.5 million in Ernest Health Holdings, LLC, which is the owner of Ernest. These investments are structured as a $93.2 million acquisition loan and a $3.3 million equity contribution.
	The interest rate on the acquisition loan is 15%. Ernest is required to pay us a minimum of 6% and 7% of the loan amount in years one and two, respectively, and 10% thereafter, although there are provisions in the loan agreement that are expected to result in full payment of the 15% preference when funds are sufficient. Any of the 15% in excess of the minimum that is not paid may be accrued and paid upon the occurrence of a capital or liquidity event and is payable at maturity. The loan may be prepaid without penalty at any time.
	As part of these acquisitions, we purchased and invested in the following: (in thousands)
		2013			2012
	Land	$	16,220		$	—
	Building		265,030			—
	Net investments in direct financing leases		85,000			310,000
	Mortgage loans		—			200,000
	Other loans		5,250			93,200
	Equity investments		—			3,300
	Total	$	371,500		$	606,500
	From the respective acquisition dates, the properties and mortgage loans acquired in 2013 contributed $2.9 million and $3.3 million of revenue and income (excluding related acquisition expenses), respectively, for the three and nine month periods ended September 30, 2013, respectively. In addition, we incurred $1.6 million and $1.6 million of acquisition related costs on the 2013 acquisitions for the three and nine months ended September 30, 2013.
	The purchase price allocation attributable to the IASIS facilities is preliminary as we are waiting on additional information to perform our final analysis. When all relevant information is obtained, resulting in changes, if any, to our provisional purchase price allocation will be retrospectively adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date.
	The results of operations for each of the properties acquired are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2012, as if each acquisition in 2013 and 2012 were consummated on the same terms at the beginning of 2012 and 2011, respectively. Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred in the three and nine months ended September 30, 2012 ($ amounts in thousands, except per share/unit data).
		For the Three Months Ended							For the Nine Months Ended
		September 30,							September 30,
		2013			2012				2013				2012
	Total revenues	$	65,518		$	63,695			$	196,708			$	188,339
	Net income		29,366			37,091				89,570				92,620
	Net income per share/unit — diluted	$	0.18		$	0.25			$	0.55			$	0.63
	Development Activities
	On June 11, 2013, we entered into a master funding and development agreement with First Choice ER, LLC (“First Choice”) to develop up to 25 freestanding emergency room facilities for a maximum aggregate funding of $100 million. During the third quarter of 2013, we began construction on two of these emergency room facilities in Dallas, Texas and Austin, Texas for a total development price of $5.2 million and $5.5 million, respectively. One of the facilities is expected to be completed in the fourth quarter of 2013, while the other in the first quarter of 2014. We have funded $4.3 million through the end of the 2013 third quarter.
	On May 20, 2013, we entered into an agreement to finance the development of and lease an inpatient rehabilitation facility in South Ogden, Utah for $19.2 million, which will be leased to Ernest under the 2012 master lease. The facility is expected to be completed in the 2014 third quarter. We have funded $7.4 million through the end of the 2013 third quarter.
	On March 4, 2013, we entered into an agreement to finance the development of and lease an inpatient rehabilitation facility in Post Falls, Idaho for $14.4 million, which will be leased to Ernest under the 2012 master lease. The facility is expected to be completed in the fourth quarter of 2013. We have funded $10.4 million through the end of the 2013 third quarter.
	In regards to our Twelve Oaks facility, approximately 55% of this facility became occupied as of January 23, 2013, pursuant to a 15 year lease.
	On December 20, 2012, we entered into an agreement to finance the development of and lease an acute care facility in Altoona, Wisconsin for $33.5 million, which will be leased to an affiliate of National Surgical Hospitals. The facility is expected to be completed in the fourth quarter of 2014. We have funded $11.1 million through the end of the 2013 third quarter.
	On October 1, 2012, we agreed to fund the construction of an inpatient rehabilitation hospital in Spartanburg, South Carolina that will be operated by Ernest. The facility opened in the third quarter of 2013, and the cost of the land and building for this facility approximates $15 million. The initial lease term for this property is approximately 20 years.
	On June 13, 2012, we entered into an agreement with Ernest to fund the development of and lease a 40-bed rehabilitation hospital in Lafayette, Indiana. The facility opened in the first quarter of 2013, and the cost of the land and building for this facility approximates $15 million. The initial lease term for this property is approximately 20 years.
	On May 4, 2012, we agreed to develop and lease a 26-bed facility next to our current facility in Victoria, Texas. Total development cost of the new facility is estimated to be $9.4 million, and it is expected to be completed in fourth quarter of 2013. We have funded $8.4 million through the end of the 2013 third quarter.
	On October 14, 2011, we entered into agreements with a joint venture of Emerus Holding, Inc. and Vanguard Health System, a subsidiary of Baptist Health System, to acquire, provide for development funding and lease three emergency care focused acute care hospitals for $30.0 million in the suburban markets of San Antonio, Texas. The three facilities are subject to a master lease structure with an initial term of 15 years and three five-year extension options. Rent escalates annually based on consumer priced indexed increases and to be not less than one percent or greater than three percent. One of these properties was completed in the fourth quarter of 2012 with the remaining two being completed in the first quarter of 2013.
	See table below for a status update on our current development projects (in thousands):
	Property	Location		Property Type	Operator		Original				Costs				Estimated
							Commitment				Incurred as				Completion
											of September 30,				Date
											2013
	Victoria Rehabilitation Hospital	Victoria, TX		Long-term Acute	Post Acute Medical		$	9,400			$	8,391				4th Qtr 2013
				Care Hospital
	First Choice ER — Brodie	Austin, TX		General Acute	First Choice			5,470				1,509				1st Qtr 2014
				Care Hospital
	First Choice ER — Little Elm	Dallas, TX		General Acute	First Choice			5,200				2,792				4th Qtr 2013
				Care Hospital
	Rehabilitation Hospital of the Northwest	Post Falls, ID		Rehabilitation	Ernest Health, Inc.			14,387				10,389				4th Qtr 2013
				Hospital
	Oakleaf Surgical Hospital	Altoona, WI		General Acute	National Surgical			33,500				11,146				3rd Qtr 2014
				Care Hospital	Hospitals
	Northern Utah Rehabilitation Hospital	South Ogden, UT		Rehabilitation	Ernest Health, Inc.			19,153				7,406				3rd Qtr 2014
				Hospital
	First Choice Emergency Rooms	Various		General Acute	First Choice			89,330				—				Various
				Care Hospital
							$	176,440			$	41,633
Disposals
In April 2013, we sold two long-term acute care hospitals, Summit Hospital of Southeast Arizona and Summit Hospital of Southeast Texas, for total proceeds of $18.5 million, resulting in a gain of $2.1 million.
On June 15, 2012, we sold the HealthSouth Rehabilitation Hospital of Fayetteville in Fayetteville, Arkansas for $16 million, resulting in a loss of $1.4 million.
On August 21, 2012, we sold our Denham Springs facility for $5.2 million, resulting in a gain of $0.3 million.
On September 28, 2012, we sold our Thornton facility for $17.4 million, resulting in a gain of $8.4 million.
Leasing Operations
On July 3, 2012, we entered into master lease agreements with certain subsidiaries of Prime, which replaced the then current leases with the same tenants covering the same properties. The master leases are for 10 years and contain two renewal options of five years each. The initial lease rate is generally consistent with the blended average rate of the prior lease agreements. However, the annual escalators, which in the prior leases were limited, have been increased 100% of consumer price index increases, along with a minimum floor. The master leases include repurchase options substantially similar to those in the prior leases, including provisions establishing minimum repurchase prices equal to our total investment.
All of our leases are accounted for as operating leases except for the master lease of 13 Ernest facilities and four other facilities which are accounted for as DFLs. The components of our net investment in DFL consisted of the following (dollars in thousands):
	As of September 30,			As of December 31,
	2013			2012
Minimum lease payments receivable	$	1,566,155		$	1,277,923
Estimated residual values		211,283			201,283
Less: Unearned income		(1,373,926	)		(1,164,794	)
Net investment in direct financing leases	$	403,512		$	314,412
Monroe facility
As of September 30, 2013, we have advanced $29.9 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana, pursuant to a working capital loan agreement and also have $21.0 million of rent, interest and other charges owed to us by the operator, of which $6.0 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During 2010, we recorded a $12 million impairment charge on the working capital loan and recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. We have not recognized any interest income on the Monroe loan since it was considered impaired, have not recorded any unbilled (straight-line) rent since 2010, and stopped recording current rent on April 1, 2013 until we begin receiving cash payments.
At September 30, 2013, our net investment (exclusive of the related real estate) of approximately $39 million is our maximum exposure to Monroe and the amount is presently deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in (i) approximately $4 million in hospital patient receivables, (ii) cash balances of $0.1 million, (iii) our assessment of the realizable value of our other collateral and (iv) projected EBITDA of the hospital operations that we have modeled under various scenarios for sensitivity purposes. Although we believe our net investment in Monroe at September 30, 2013, is recoverable, no assurances can be made that we will not have additional impairment charges on our working capital loan or other receivables in the future.
Florence facility
On March 1, 2012, we received a certificate of occupancy for our approximate $30 million Florence acute care facility constructed near Phoenix, Arizona. With this, we started collecting and recognizing rent on this facility in March 2012. On March 6, 2013, the tenant of this facility filed for Chapter 11 bankruptcy. Florence is current on rent, and at September 30, 2013, we had less than $0.5 million of receivables outstanding. In addition, we have a letter of credit for approximately $1.2 million to cover any rent and other monetary payments not paid in the future. Although no assurances can be made that we will not have any impairment charges in the future, we believe our investment in Florence at September 30, 2013, is fully recoverable.
Loans
The following is a summary of our loans (in thousands):
	As of			As of
	September 30,			December 31,
	2013			2012
Mortgage loans	$	368,650		$	368,650
Acquisition loans		103,516			98,433
Working capital and other loans		54,377			57,458
Convertible loan		3,352			3,352
	$	529,895		$	527,893
Our mortgage loans cover 9 of our properties with three operators.
On March 1, 2012, pursuant to our convertible note agreement, we converted $1.7 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At September 30, 2013, $3.3 million remains outstanding on the convertible note, and we retain the option, through November 2014, to convert this remainder into 15.1% of equity interest in the operator.
Concentrations of Credit Risk
For the three months ended September 30, 2013 and 2012, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 20.7% and 21.1%, respectively, of total revenue. For the nine months ended September 30, 2013 and 2012, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 20.5% and 18.4%, respectively, of total revenue. From an investment concentration perspective, Ernest represented 17.4% and 18.2% of our total assets at September 30, 2013 and December 31, 2012, respectively.
For the three months ended September 30, 2013 and 2012, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 33.7% and 28.7%, respectively, of total revenue. For the nine months ended September 30, 2013 and 2012, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 32.4% and 26.0%, respectively, of total revenue. From an investment concentration perspective, Prime represented 26.7% and 27.9% of our total assets at September 30, 2013 and December 31, 2012, respectively.
On an individual property basis, we had no investment of any single property greater than 5% of our total assets as of September 30, 2013.
From a geographic perspective, all of our properties are currently located in the United States with 24.5% and 20.4% of our total assets at September 30, 2013, located in Texas and California, respectively.

Debt

Debt	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Debt	'
	4. Debt
	The following is a summary of debt, net of discounts (dollar amounts in thousands):
			As of September 30,					As of December 31,
			2013					2012
			Balance		Interest Rate			Balance			Interest Rate
	Revolving credit facility		$	45,000		Variable		$	125,000			Variable
	2006 Senior Unsecured Notes			125,000		Various			125,000			Various
	2011 Senior Unsecured Notes			450,000		6.875	%		450,000			6.875	%
	2012 Senior Unsecured Notes:
	Principal amount			350,000		6.375	%		200,000			6.375	%
	Unamortized premium			2,960					—			—
				352,960					200,000
	Exchangeable senior notes:
	Principal amount (A)			—		N/A			11,000			9.25	%
	Unamortized discount			—					(37	)
				—					10,963
	Term loans			114,013		Various			114,197			Various
			$	1,086,973				$	1,025,160
	As of September 30, 2013, principal payments due for our debt (which exclude the effects of any discounts or premiums recorded) are as follows (in thousands):
	2013		$	64
	2014			266
	2015			45,283
	2016			225,299
	2017			320
	Thereafter			812,781
	Total		$	1,084,013
	(A)	The exchangeable senior notes were paid in full on April 1, 2013.
	To help fund acquisitions described in Note 3, on February 17, 2012 and August 20, 2013, we issued $200.0 million (resulting in net proceeds of $196.5 million, after underwriting discount) and $150.0 million (resulting in net proceeds of $150.3 million, after underwriting discount), respectively, aggregate principal amount of our 6.375% senior notes due 2022. The 2013 issuance, which was a tack on to the 2012 offering, was issued at a price of 102%, which represents a yield to the par redemption date of February 15, 2020 of 5.998%.
	In addition, on March 9, 2012, we closed on a $100 million senior unsecured term loan facility (“2012 Term Loan”) and exercised the $70 million accordion feature on our revolving credit facility, increasing its capacity from $330 million to $400 million.
	During the second quarter 2010, we entered into an interest rate swap to manage our exposure to variable interest rates by fixing $65 million of our 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. The fair value of the interest rate swaps was $9.7 million and $12.5 million as of September 30, 2013 and December 31, 2012, respectively, which is reflected in accounts payable and accrued expenses on the consolidated balance sheets.
	We designated our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effect earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness in the periods; therefore, there was no income statement effect recorded during the three and nine month periods ended September 30, 2013 or 2012. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months. At September 30, 2013 and December 31, 2012, we had $4.7 million and $6.6 million, respectively, posted as collateral, which is currently reflected in other assets on our consolidated balance sheets.
	Covenants
	Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our revolving credit facility and 2012 Term Loan limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis. The dividend restriction is currently 95% of normalized adjusted FFO. The indentures governing our 2011 and 2012 Senior Unsecured Notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our 2011 and 2012 Senior Unsecured Notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.
	In addition to these restrictions, the revolving credit facility and 2012 Term Loan contain customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and unsecured interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At September 30, 2013, we were in compliance with all such financial and operating covenants.

Common_StockPartners_Capital

Common Stock/Partners' Capital	9 Months Ended
	Sep. 30, 2013
Text Block [Abstract]	'
Common Stock/Partners' Capital	'
	5. Common Stock/Partners’ Capital
	Medical Properties Trust, Inc.
	On August 20, 2013, we completed an offering of 11,500,000 shares of common stock (including 1,500,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares) at a price of $12.75 per share, resulting in net proceeds (after underwriting discount and expenses) of $140.4 million. These proceeds were used to fund the acquisition of the three IASIS properties more fully described in Note 3.
	On February 28, 2013, we completed an offering of 12,650,000 shares of our common stock (including 1,650,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares) at a price of $14.25 per share, resulting in net proceeds (after underwriting discount and expenses) of $172.9 million. A portion of the net proceeds from this offering were used to pay down our revolving credit facility.
	To help fund the 2012 acquisitions disclosed in Note 3, on February 7, 2012, we completed an offering of 23,575,000 shares of our common stock (including 3,075,000 shares sold pursuant to the exercise in full of the underwriters’ overallotment option) at a price of $9.75 per share, resulting in net proceeds (after underwriting discount) of $220.1 million.
	MPT Operating Partnership, L.P.
	At September 30, 2013, the Company has a 99.8% ownership interest in Operating Partnership with the remainder owned by three other partners, two of which are employees and one of which is a director. During the nine months ended September 30, 2013 and 2012, the partnership issued 24,150,000 and 23,575,000 units, respectively, in direct response to the common stock offerings by Medical Properties Trust, Inc.

Stock_Awards

Stock Awards	9 Months Ended
	Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Stock Awards	'
	6. Stock Awards
	We adopted the 2013 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2013, which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan replaced the 2004 Equity Incentive Plan (“2004 Plan”). The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,395,132 shares of common stock for awards under the Equity Incentive Plan (including 495,132 remaining shares under the 2004 Plan that were transferred to the Equity Incentive Plan) for which 7,395,132 shares remain available for future stock awards as of September 30, 2013. For each share of common stock issued by Medical Properties Trust, Inc. pursuant to the Equity Incentive Plan, the Operating Partnership issues a corresponding number of operating partnership units. We awarded the following stock awards during the 2013 and 2012 first quarters:
	Time-based awards—We granted 240,425 and 275,464 shares in 2013 and 2012, respectively, of time-based restricted stock to management and independent directors. These awards vest quarterly based on service, over three years, in equal amounts.
	Performance-based awards—Our management team and certain employees (2012 only) were awarded 204,255 and 252,566 performance based awards in 2013 and 2012, respectively. These awards vest ratably over a three year period based on the achievement of certain total shareholder return measures, with a carry-back and carry-forward provision through December 31, 2016 (for the 2012 awards) and December 31, 2017 (for the 2013 awards). Dividends on these awards are paid only upon achievement of the performance measures.
	Multi-year Performance-based awards—We awarded 550,000 and 649,793 shares in 2013 and 2012, respectively, of multi-year performance-based awards to management and certain employees (2012 only). These shares are subject to three-year cumulative performance hurdles based on measures of total shareholder return. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	7. Fair Value of Financial Instruments
	We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans are estimated by using Level 2 inputs (except for the Monroe loan for which we use Level 3 inputs) such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes and 2011 and 2012 Senior Unsecured Notes, using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, revolving credit facilities, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.
	Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):
			September 30,						December 31,
			2013						2012
	Asset (Liability)		Book			Fair			Book			Fair
			Value			Value			Value			Value
	Interest and rent receivables		$	54,505		$	43,723		$	45,289		$	36,700
	Loans (1)			331,612			329,367			334,693			335,595
	Debt, net			(1,086,973	)		(1,116,389	)		(1,025,160	)		(1,082,333	)
	-1	Excludes loans related to the Ernest Transaction since they are recorded at fair value and discussed below.
	Items Measured at Fair Value on a Recurring Basis
	Our equity interest in Ernest and related loans, as discussed in Note 3, are being measured at fair value on a recurring basis as we elected to account for these investments using the fair value option method. We have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans in or prior to 2013.
	At September 30, 2013, these amounts were as follows (in thousands):
	Asset Type		Fair			Cost			Asset Type
			Value						Classification
	Mortgage loans		$	100,000		$	100,000			Mortgage loans
	Acquisition loan			98,283			98,283			Other loans
	Equity investments			3,300			3,300			Other assets
			$	201,583		$	201,583
	Our mortgage loans with Ernest are recorded at fair value based on Level 3 inputs by discounting the estimated cash flows using the market rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loan and equity investments in Ernest are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecast assumptions associated with the investee. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include use of a capitalization rate, discount rate (which is based on a weighted-average cost of capital), and market interest rates, and our unobservable input includes an adjustment for a marketability discount (“DLOM”) on our equity investment of 40% at September 30, 2013.
	In regards to the underlying projection of revenues and expenses used in the discounted cash flow model, such projections are provided by Ernest. However, we will modify such projections (including underlying assumptions used) as needed based on our review and analysis of Ernest’s historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry.
	In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):
	Basis Point		Estimated Increase (Decrease)
			In Fair Value
	Change in
	Marketability Discount
	+100 basis points		$	(300	)
	- 100 basis points			300
	Because the fair value of Ernest investments noted above approximate their original cost, we did not recognize any unrealized gains/losses during the first nine months of 2013. To date, we have not received any distribution payments from our equity investment in Ernest.

Discontinued_Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2013
Discontinued Operations And Disposal Groups [Abstract]	'
Discontinued Operations	'
	8. Discontinued Operations
	Including those properties discussed in Note 3 under the heading “Disposals”, we sold two properties during the nine month period ending September 30, 2013 and five properties during 2012. We have classified current and prior year activity related to these transactions, along with the related operating results of the facilities prior to these transactions taking place, as discontinued operations. In addition, we have reclassified the related real estate assets to Real Estate Held for Sale in all prior periods.
	The following table presents the results of discontinued operations, for the three and nine months ended September 30, 2013 and 2012 (dollar amounts in thousands except per share/unit amounts):
		For the Three Months				For the Nine Months
		Ended September 30,				Ended September 30,
		2013		2012		2013		2012
	Revenues	$	37	$	460	$	568	$	5,919
	Gain (loss) on sale		—		8,726		2,054		7,280
	Income		37		8,643		2,498		11,050
	Earnings per share/unit — diluted	$	—	$	0.06	$	0.02	$	0.08

Earnings_Per_ShareCommon_Unit

Earnings Per Share/Common Unit	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share/Common Unit	'
	9. Earnings Per Share/Common Unit
	Medical Properties Trust, Inc.
	Our earnings per share were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	25,666		$	22,865
	Non-controlling interests’ share in continuing operations		(55	)		(44	)
	Participating securities’ share in earnings		(166	)		(225	)
	Income from continuing operations, less participating securities’ share in earnings		25,445			22,596
	Income from discontinued operations attributable to MPT common stockholders		37			8,643
	Net income, less participating securities’ share in earnings	$	25,482		$	31,239
	Denominator:
	Basic weighted-average common shares		154,758			134,781
	Dilutive potential common shares		1,211			1
	Dilutive weighted-average common shares		155,969			134,782
		For the Nine Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	76,819		$	50,424
	Non-controlling interests’ share in continuing operations		(165	)		(130	)
	Participating securities’ share in earnings		(538	)		(715	)
	Income from continuing operations, less participating securities’ share in earnings		76,116			49,579
	Income from discontinued operations attributable to MPT common stockholders		2,498			11,050
	Net income, less participating securities’ share in earnings	$	78,614		$	60,629
	Denominator:
	Basic weighted-average common shares		148,204			131,467
	Dilutive potential common shares		1,313			—
	Dilutive weighted-average common shares		149,517			131,467
	MPT Operating Partnership, L.P.
	Our earnings per common unit were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	25,666		$	22,865
	Non-controlling interests’ share in continuing operations		(55	)		(44	)
	Participating securities’ share in earnings		(166	)		(225	)
	Income from continuing operations, less participating securities’ share in earnings		25,445			22,596
	Income from discontinued operations attributable to MPT Operating Partnership partners		37			8,643
	Net income, less participating securities’ share in earnings	$	25,482		$	31,239
	Denominator:
	Basic weighted-average units		154,758			134,781
	Dilutive potential units		1,211			1
	Dilutive weighted-average units		155,969			134,782
		For the Nine Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	76,819		$	50,424
	Non-controlling interests’ share in continuing operations		(165	)		(130	)
	Participating securities’ share in earnings		(538	)		(715	)
	Income from continuing operations, less participating securities’ share in earnings		76,116			49,579
	Income from discontinued operations attributable to MPT Operating Partnership partners		2,498			11,050
	Net income, less participating securities’ share in earnings	$	78,614		$	60,629
	Denominator:
	Basic weighted-average units		148,204			131,467
	Dilutive potential units		1,313			—
	Dilutive weighted-average units		149,517			131,467
	For the three and nine months ended September 30, 2012, 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive. In addition, shares/units that may be issued in the future in accordance with our exchangeable senior notes (which were paid off in April 1, 2013) were excluded from the 2012 diluted earnings per share/unit calculation as they were not determined to be dilutive.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	10. Commitments and Contingencies
	Contingencies
	We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.
	Commitments
	RHM Portfolio Acquisition
	On September 13, 2013, we entered into an agreement to acquire 11 rehabilitation facilities in the Federal Republic of Germany from RHM Klinik-und Altenheimbetriebe GmbH & Co. KG (“RHM”) for an aggregate purchase price, including payment of applicable transfer taxes, of €184.0 million (plus a commitment to provide up to €10.0 million in financing for the construction of additions to the facilities within the next two years)(“RHM Portfolio Acquisition”). Each of the facilities will be leased back to RHM under a master lease providing for a term of 27 years and for annual rent increases of 2.0% from 2015 through 2017, and of 0.5% thereafter. On December 31, 2020 and every three years thereafter, rent will also be increased to reflect 70% of cumulative increases in the German consumer price index.
	The RHM Portfolio Acquisition will represent our first acquisition outside of the United States; however the deal is currently structured similarly to our transactions in the United States. This acquisition would add a portfolio of assets with a financially stable long-term operating history backed by an international private equity sponsor.
	Pursuant to the terms of the acquisition agreement, if the conditions precedent to acquiring the 11 facilities are not satisfied or waived on or prior to 90 days after the date of the acquisition agreement, we and the seller will each have the option to close the RHM Portfolio Acquisition with respect to a lesser number of facilities and for a reduced aggregate purchase price. We intend to consummate the RHM Portfolio Acquisition during the fourth quarter of 2013. No assurance can be given that any portion of the RHM Portfolio Acquisition will occur as described herein or at all.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	11. Subsequent Events
	On October 16, 2013, we began construction on a free standing emergency room facility in San Antonio, Texas that will be leased to First Choice, for a total development price of $5.2 million. The facility is expected to be completed in the first quarter of 2014.
	In order to fund the RHM Portfolio Acquisition, on October 10, 2013, we completed a public offering of €200 million aggregate principal amount of our 5.750% Senior Notes due 2020 (the “Notes”). Interest on the Notes will be payable semi-annually on April 1 and October 1 of each year, commencing on April 1, 2014. The Notes will pay interest in cash at a rate of 5.750% per year. The Notes mature on October 1, 2020. We may redeem some or all of the Notes at any time prior to October 1, 2016 at a “make-whole” redemption price. On or after October 1, 2016, we may redeem some or all of the Notes at a premium that will decrease over time. In addition, at any time and from time to time prior to October 1, 2016 the Issuers may redeem up to 35% of the aggregate principal amount of the Notes using the proceeds of one or more equity offerings. The Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by certain subsidiary guarantors. In the event of a Change of Control, each holder of the Notes may require us to repurchase some or all of our Notes at a repurchase price equal to 101% of the aggregate principal amount of the Notes plus accrued and unpaid interest to the date of purchase.
	Proceeds from this offering are currently in escrow and our receipt of such proceeds is dependent on closing of the RHM Portfolio Acquisition. If the conditions to closing the RHM Portfolio Acquisition (other than the payment of the acquisition consideration and other than those conditions that by their terms are to be satisfied contemporaneously with the consummation of the RHM Portfolio Acquisition) are not satisfied or waived on or prior to 90 days after the closing date of this offering of Notes, we will be required by the terms of the indenture governing the Notes to redeem the Notes at the aggregate offering price plus accrued and unpaid interest up to, but excluding, the redemption date.

Condensed_Consolidating_Financ

Condensed Consolidating Financial Information	9 Months Ended
	Sep. 30, 2013
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]	'
Condensed Consolidating Financial Information	'
	12. Condensed Consolidating Financial Information
	The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. (“Parent” and a guarantor to our 2011 and 2012 Senior Unsecured Notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation (“Subsidiary Issuer”), (c) on a combined basis, the guarantors of our 2011 and 2012 Senior Unsecured Notes (“Subsidiary Guarantors”), and (d) on a combined basis, the non-guarantor subsidiaries (“Non-Guarantor Subsidiaries”). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent’s ability to obtain funds from its subsidiaries by dividend or loan.
	The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as “unrestricted” for covenant purposes under the indenture governing the 2011 and 2012 Senior Unsecured Notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011 and 2012 Senior Unsecured Notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.
	Subsequent to September 30, 2012, certain of our subsidiaries were re-designated as non-guarantors of our 2011 and 2012 Senior Unsecured Notes as the underlying properties were sold in 2012 and the first half of 2013. With these re-designations, we have restated the 2012 condensed consolidating financial information below to reflect these changes.
	In the second quarter of 2013, we revised our condensed consolidating balance sheets as of December 31, 2012 and 2011 to adjust negative net intercompany receivables (payable) balances from Total Assets to Total Liabilities. The impact of this revision, was to increase total assets (and, correspondingly increase total liabilities) as of December 31, 2012 and 2011 for Subsidiaries Guarantors by $1,010.4 million and $888.9 million, respectively, and also to increase total assets (and, correspondingly increase total liabilities) for Non-Guarantor Subsidiaries by $390.9 million and $5.5 million respectively, with an offset to Eliminations. This revision is not material to the related financial statements for any prior periods and had no impact on our consolidated balance sheet. As prior period financial information is presented in future filings, we will similarly revise the condensed consolidating balance sheets.
	Condensed Consolidated Balance Sheet
	30-Sep-13
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Assets
	Real estate assets
	Land, buildings and improvements and intangible lease assets	$	—		$	—		$	1,259,234		$	347,198		$	—		$	1,606,432
	Mortgage loans		—			—			268,650			100,000			—			368,650
	Net investment in direct financing leases		—			—			186,586			216,926			—			403,512
	Gross investment in real estate assets		—			—			1,714,470			664,124			—			2,378,594
	Accumulated depreciation and amortization		—			—			(142,939	)		(7,727	)		—			(150,666	)
	Net investment in real estate assets		—			—			1,571,531			656,397			—			2,227,928
	Cash and cash equivalents		—			11,391			—			733			—			12,124
	Interest and rent receivable		—			715			29,284			24,506			—			54,505
	Straight-line rent receivable		—			—			36,051			8,189			—			44,240
	Other loans		—			178			—			161,067			—			161,245
	Net intercompany receivable		32,053			1,639,081			—			—			(1,671,134	)		—
	Investment in subsidiaries		1,358,959			783,441			43,557			—			(2,185,957	)		—
	Other assets		—			32,534			980			29,594			—			63,108
	Total Assets	$	1,391,012		$	2,467,340		$	1,681,403		$	880,486		$	(3,857,091	)	$	2,563,150
	Liabilities and Equity
	Liabilities
	Debt, net	$	—		$	1,072,960		$	—		$	14,013		$	—		$	1,086,973
	Accounts payable and accrued expenses		32,443			35,705			4,935			769			—			73,852
	Net intercompany payable		—			—			998,987			672,147			(1,671,134	)		—
	Deferred revenue		—			(284	)		17,970			5,543			—			23,229
	Lease deposits and other obligations to tenants		—			—			17,923			2,604			—			20,527
	Total liabilities		32,443			1,108,381			1,039,815			695,076			(1,671,134	)		1,204,581
	Total equity		1,358,569			1,358,959			641,588			185,410			(2,185,957	)		1,358,569
	Total Liabilities and Equity	$	1,391,012		$	2,467,340		$	1,681,403		$	880,486		$	(3,857,091	)	$	2,563,150
	Condensed Consolidated Statements of Income
	For the Three Months Ended September 30, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Revenues
	Rent billed	$	—		$	—		$	29,770		$	5,403		$	(3,295	)	$	31,878
	Straight-line rent		—			—			2,189			664			—			2,853
	Income from direct financing leases		—			—			10,519			5,750			(4,971	)		11,298
	Interest and fee income		—			5,004			9,161			7,299			(7,037	)		14,427
	Total revenues		—			5,004			51,639			19,116			(15,303	)		60,456
	Expenses
	Real estate depreciation and amortization		—			—			8,363			426			—			8,789
	Property-related		—			182			251			8,291			(8,266	)		458
	General and administrative		—			6,867			—			(487	)		—			6,380
	Acquisition expenses		—			4,179			—			—			—			4,179
	Total operating expenses		—			11,228			8,614			8,230			(8,266	)		19,806
	Operating income (expense)		—			(6,224	)		43,025			10,886			(7,037	)		40,650
	Other income (expense)
	Other income (expense)		—			5			—			(2	)		—			3
	Earnings from equity and other interests		—			—			454			389			—			843
	Interest income (expense)		—			(16,055	)		454			(7,266	)		7,037			(15,830	)
	Net other income (expense)		—			(16,050	)		908			(6,879	)		7,037			(14,984	)
	Income (loss) from continuing operations		—			(22,274	)		43,933			4,007			—			25,666
	Income from discontinued operations		—			—			—			37			—			37
	Equity in earnings of consolidated subsidiaries, net of income taxes		25,703			47,977			1,114			—			(74,794	)		—
	Net income		25,703			25,703			45,047			4,044			(74,794	)		25,703
Net income (loss) attributable to non-controlling interests		(55	)		(55	)		—			—			55			(55	)
Net income attributable to MPT common stockholders	$	25,648		$	25,648		$	45,047		$	4,044		$	(74,739	)	$	25,648
Condensed Consolidated Statements of Income
For the Nine Months Ended September 30, 2013
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed	$	—		$	—		$	89,149		$	14,970		$	(9,045	)	$	95,074
Straight-line rent		—			—			6,617			1,643			—			8,260
Income from direct financing leases		—			—			27,387			16,744			(14,847	)		29,284
Interest and fee income		—			15,112			27,565			21,816			(21,211	)		43,282
Total revenues		—			15,112			150,718			55,173			(45,103	)		175,900
Expenses
Real estate depreciation and amortization		—			—			24,775			1,276			—			26,051
Property-related		—			458			792			24,162			(23,892	)		1,520
General and administrative		—			21,286			—			137			—			21,423
Acquisition expenses		—			6,457			—			—			—			6,457
Total operating expenses		—			28,201			25,567			25,575			(23,892	)		55,451
Operating income (expense)		—			(13,089	)		125,151			29,598			(21,211	)		120,449
Other income (expense)
Other income (expense)		—			(37	)		—			(208	)		—			(245	)
Earnings from equity and other interests		—			—			687			1,824			—			2,511
Interest income (expense)		—			(46,298	)		1,083			(21,892	)		21,211			(45,896	)
Net other income (expense)		—			(46,335	)		1,770			(20,276	)		21,211			(43,630	)
Income (loss) from continuing operations		—			(59,424	)		126,921			9,322			—			76,819
Income from discontinued operations		—			—			(4	)		2,502			—			2,498
Equity in earnings of consolidated subsidiaries net of income taxes		79,317			138,741			3,356			—			(221,414	)		—
Net income		79,317			79,317			130,273			11,824			(221,414	)		79,317
Net income (loss) attributable to non-controlling interests		(165	)		(165	)		—			—			165			(165	)
Net income attributable to MPT common stockholders	$	79,152		$	79,152		$	130,273		$	11,824		$	(221,249	)	$	79,152
Condensed Consolidated Statements of Comprehensive Income
For the Three Months Ended September 30, 2013
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Net income	$	25,703		$	25,703		$	45,047		$	4,044		$	(74,794	)	$	25,703
Other comprehensive income:
Unrealized gain on interest rate swap		182			182			—			—			(182	)		182
Total comprehensive income		25,885			25,885			45,047			4,044			(74,976	)		25,885
Comprehensive income attributable to non-controlling interests		(55	)		(55	)		—			—			55			(55	)
Comprehensive income attributable to MPT common stockholders	$	25,830		$	25,830		$	45,047		$	4,044		$	(74,921	)	$	25,830
Condensed Consolidated Statements of Comprehensive Income
For the Nine Months Ended September 30, 2013
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Net income	$	79,317		$	79,317		$	130,273		$	11,824		$	(221,414	)	$	79,317
Other comprehensive income:
Unrealized gain on interest rate swap		2,788			2,788			—			—			(2,788	)		2,788
Total comprehensive income		82,105			82,105			130,273			11,824			(224,202	)		82,105
Comprehensive income attributable to non-controlling interests		(165	)		(165	)		—			—			165			(165	)
Comprehensive income attributable to MPT common stockholders	$	81,940		$	81,940		$	130,273		$	11,824		$	(224,037	)	$	81,940
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2013
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	91		$	(38,891	)	$	156,913		$	(16,549	)	$	—		$	101,564
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(95,000	)		(276,500	)		—			(371,500	)
Principal received on loans receivable		—			—			—			4,694			—			4,694
Net proceeds from sale of real estate		—			—			—			18,409			—			18,409
Investments in and advances to subsidiaries		(225,683	)		(267,545	)		(1,506	)		269,142			225,592			—
Investments in loans receivable		—			—			—			(1,445	)		—			(1,445	)
Construction in progress and other		—			(765	)		(63,691	)		1,034			—			(63,422	)
Net cash provided by (used in) investing activities		(225,683	)		(268,310	)		(160,197	)		15,334			225,592			(413,264	)
Financing Activities
Revolving credit facilities, net		—			(80,000	)		—			—			—			(80,000	)
Additions to term debt, net of discount		—			153,000			—			—			—			153,000
Payments of term debt		—			(11,000	)		—			(185	)		—			(11,185	)
Distributions paid		(87,727	)		(87,928	)		—			—			87,727			(87,928	)
Proceeds from sale of common shares/units, net of offering costs		313,319			313,319			—			—			(313,319	)		313,319
Lease deposits and other obligations to tenants		—			—			1,719			1,870			—			3,589
Debt issuance costs paid and other financing activities		—			(4,282	)		—			—			—			(4,282	)
Net cash provided by financing activities		225,592			283,109			1,719			1,685			(225,592	)		286,513
Increase (decrease) in cash and cash equivalents for period		—			(24,092	)		(1,565	)		470			—			(25,187	)
Cash and cash equivalents at beginning of period		—			35,483			1,565			263			—			37,311
Cash and cash equivalents at end of period	$	—		$	11,391		$	—		$	733		$	—		$	12,124
Condensed Consolidated Balance Sheet
31-Dec-12
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—		$	28		$	1,196,124		$	65,947		$	—		$	1,262,099
Real estate held for sale		—			—			—			16,497			—			16,497
Mortgage loans		—			—			268,650			100,000			—			368,650
Investment in direct financing leases		—			—			110,155			204,257			—			314,412
Gross investment in real estate assets		—			28			1,574,929			386,701			—			1,961,658
Accumulated depreciation and amortization		—			—			(118,163	)		(6,452	)		—			(124,615	)
Net investment in real estate assets		—			28			1,456,766			380,249			—			1,837,043
Cash and cash equivalents		—			35,483			1,565			263			—			37,311
Interest and rent receivable		—			212			29,159			15,918			—			45,289
Straight-line rent receivable		—			—			29,314			6,546			—			35,860
Other loans		—			177			—			159,066			—			159,243
Net intercompany receivable		27,393			1,373,941			—			—			(1,401,334	)		—
Investment in subsidiaries		1,050,204			647,029			42,666			—			(1,739,899	)		—
Other assets		—			31,097			1,522			31,521			—			64,140
Total Assets	$	1,077,597		$	2,087,967		$	1,560,992		$	593,563		$	(3,141,233	)	$	2,178,886
Liabilities and Equity
Liabilities
Debt, net	$	—		$	1,010,962		$	—		$	14,198		$	—		$	1,025,160
Accounts payable and accrued expenses		27,783			26,658			10,492			1,028			—			65,961
Net intercompany payable		—			—			1,000,117			401,217			(1,401,334	)		—
Deferred revenue		—			143			19,621			845			—			20,609
Lease deposits and other obligations to tenants		—			—			16,606			736			—			17,342
Total liabilities		27,783			1,037,763			1,046,836			418,024			(1,401,334	)		1,129,072
Total equity		1,049,814			1,050,204			514,156			175,539			(1,739,899	)		1,049,814
Total Liabilities and Equity	$	1,077,597		$	2,087,967		$	1,560,992		$	593,563		$	(3,141,233	)	$	2,178,886
Condensed Consolidated Statements of Income
For the Three Months Ended September 30, 2012
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed	$	—		$	—		$	28,470		$	4,163		$	(2,335	)	$	30,298
Straight-line rent		—			—			2,371			374			—			2,745
Income from direct financing leases		—			—			5,238			5,394			(4,859	)		5,773
Interest and fee income		—			5,242			8,917			6,943			(7,065	)		14,037
Total revenues		—			5,242			44,996			16,874			(14,259	)		52,853
Expenses
Real estate depreciation and amortization		—			—			7,883			425			—			8,308
Property-related		—			88			116			7,204			(7,194	)		214
General and administrative		—			6,332			—			720			—			7,052
Acquisition expenses		—			410			—			—			—			410
Total operating expenses		—			6,830			7,999			8,349			(7,194	)		15,984
Operating income (loss)		—			(1,588	)		36,997			8,525			(7,065	)		36,869
Other income (expense)
Other income (expense)		—			(21	)		(2	)		—			—			(23	)
Earnings from equity and other interests		—			—			331			734			—			1,065
Interest income (expense)		—			(15,203	)		388			(7,296	)		7,065			(15,046	)
Net other income (expense)		—			(15,224	)		717			(6,562	)		7,065			(14,004	)
Income (loss) from continuing operations		—			(16,812	)		37,714			1,963			—			22,865
Income (loss) from discontinued operations		—			—			314			8,329			—			8,643
Equity in earnings of consolidated subsidiaries, net of income taxes		31,508			48,320			1,129			—			(80,957	)		—
Net income		31,508			31,508			39,157			10,292			(80,957	)		31,508
Net income (loss) attributable to non-controlling interests		(44	)		(44	)		—			—			44			(44	)
Net income attributable to MPT common stockholders	$	31,464		$	31,464		$	39,157		$	10,292		$	(80,913	)	$	31,464
Condensed Consolidated Statements of Income
For the Nine Months Ended September 30, 2012
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed	$	—		$	—		$	85,160		$	12,446		$	(6,926	)	$	90,680
Straight-line rent		—			—			4,310			1,119			—			5,429
Income from direct financing leases		—			—			11,730			12,600			(11,351	)		12,979
Interest and fee income		—			13,219			20,620			17,358			(17,711	)		33,486
Total revenues		—			13,219			121,820			43,523			(35,988	)		142,574
Expenses
Real estate depreciation and amortization		—			—			23,551			1,275			—			24,826
Property-related		—			349			580			18,375			(18,277	)		1,027
General and administrative		—			20,067			—			1,274			—			21,341
Acquisition expenses		—			4,115			—			—			—			4,115
Total operating expenses		—			24,531			24,131			20,924			(18,277	)		51,309
Operating income (loss)		—			(11,312	)		97,689			22,599			(17,711	)		91,265
Other income (expense)
Other income (expense)		—			(49	)		(2	)		(4	)		—			(55	)
Earnings from equity and other interests		—			—			783			1,161			—			1,944
Interest income (expense)		—			(42,905	)		867			(18,403	)		17,711			(42,730	)
Net other income (expense)		—			(42,954	)		1,648			(17,246	)		17,711			(40,841	)
Income (loss) from continuing operations		—			(54,266	)		99,337			5,353			—			50,424
Income (loss) from discontinued operations		—			—			106			10,944			—			11,050
Equity in earnings of consolidated subsidiaries net of income taxes		61,474			115,740			3,367			—			(180,581	)		—
Net income		61,474			61,474			102,810			16,297			(180,581	)		61,474
Net income (loss) attributable to non-controlling interests		(130	)		(130	)		—			—			130			(130	)
Net income attributable to MPT common stockholders	$	61,344		$	61,344		$	102,810		$	16,297		$	(180,451	)	$	61,344
Condensed Consolidated Statements of Comprehensive Income
For the Three Months Ended September 30, 2012
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Net income	$	31,508		$	31,508		$	39,157		$	10,292		$	(80,957	)	$	31,508
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(443	)		(443	)		—			—			443			(443	)
Total comprehensive income		31,065			31,065			39,157			10,292			(80,514	)		31,065
Comprehensive income attributable to non-controlling interests		(44	)		(44	)		—			—			44			(44	)
Comprehensive income attributable to MPT common stockholders	$	31,021		$	31,021		$	39,157		$	10,292		$	(80,470	)	$	31,021
Condensed Consolidated Statements of Comprehensive Income
For the Nine Months Ended September, 30, 2012
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Net income	$	61,474		$	61,474		$	102,810		$	16,297		$	(180,581	)	$	61,474
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(989	)		(989	)		—			—			989			(989	)
Total comprehensive income		60,485			60,485			102,810			16,297			(179,592	)		60,485
Comprehensive income attributable to non-controlling interests		(130	)		(130	)		—			—			130			(130	)
Comprehensive income attributable to MPT common stockholders	$	60,355		$	60,355		$	102,810		$	16,297		$	(179,462	)	$	60,355
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2012
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	16		$	(38,780	)	$	109,018		$	4,455		$	—		$	74,709
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(410,000	)		(196,500	)		—			(606,500	)
Principal received on loans receivable		—			—			5,491			4,016			—			9,507
Net proceeds from sale of real estate		—			—			800			33,300			—			34,100
Investments in and advances to subsidiaries		(143,554	)		(540,016	)		380,605			159,427			143,538			—
Investments in loans receivable		—			—			—			(1,293	)		—			(1,293	)
Construction in progress and other		—			(59	)		(33,869	)		(1,992	)		—			(35,920	)
Net cash used in investing activities		(143,554	)		(540,075	)		(56,973	)		(3,042	)		143,538			(600,106	)
Financing Activities
Revolving credit facilities, net		—			75,000			(39,600	)		—			—			35,400
Additions to term debt		—			300,000			—			—			—			300,000
Payments of term debt		—			—			—			(171	)		—			(171	)
Distributions paid		(76,569	)		(76,770	)		—			—			76,569			(76,770	)
Proceeds from sale of common stock/units, net of offering costs		220,107			220,107			—			—			(220,107	)		220,107
Lease deposits and other obligations to tenants		—			—			(12,289	)		(1,102	)		—			(13,391	)
Debt issuance costs paid and other financing activities		—			(6,341	)		—			—			—			(6,341	)
Net cash provided by (used in) financing activities		143,538			511,996			(51,889	)		(1,273	)		(143,538	)		458,834
Increase in cash and cash equivalents for period		—			(66,859	)		156			140			—			(66,563	)
Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726
Cash and cash equivalents at end of period	$	—		$	34,371		$	1,565		$	227		$	—		$	36,163

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Unaudited Interim Condensed Consolidated Financial Statements	'
	Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended September 30, 2013, are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. The condensed consolidated balance sheet at December 31, 2012 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.
	For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2012. During the nine months ended September 30, 2013, there were no material changes to these policies.
Reclassifications	'
	Reclassifications: Certain reclassifications have been made to the condensed consolidated financial statements to conform to the 2013 consolidated financial statement presentation. These reclassifications had no impact on stockholders’ equity or net income.
Variable Interest Entities	'
	Variable Interest Entities
	At September 30, 2013, we had loans to and/or equity investments in several variable interest entities (“VIEs”) for which we are not the primary beneficiary. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2013 (in thousands):
	VIE Type		Maximum Loss		Asset Type	Carrying
			Exposure(1)		Classification	Amount(2)
	Loans, net		$	283,157	Mortgage and other loans	$	229,646
	Equity investments		$	19,519	Other assets	$	5,079
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rent receivables), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
	For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrower or investee) that most significantly impact the VIE’s economic performance. As of September 30, 2013, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).
	Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.
	See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Carrying Value and Classification of Related Assets and Maximum Exposure to Loss	'
	The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2013 (in thousands):
	VIE Type		Maximum Loss		Asset Type	Carrying
			Exposure(1)		Classification	Amount(2)
	Loans, net		$	283,157	Mortgage and other loans	$	229,646
	Equity investments		$	19,519	Other assets	$	5,079
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rent receivables), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

Real_Estate_and_Lending_Activi1

Real Estate and Lending Activities (Tables)	9 Months Ended
	Sep. 30, 2013
Leases [Abstract]	'
Assets Acquired	'
	As part of these acquisitions, we purchased and invested in the following: (in thousands)
		2013			2012
	Land	$	16,220		$	—
	Building		265,030			—
	Net investments in direct financing leases		85,000			310,000
	Mortgage loans		—			200,000
	Other loans		5,250			93,200
	Equity investments		—			3,300
	Total	$	371,500		$	606,500
Supplemental Pro Forma Earnings Adjusted to Exclude Acquisition-Related Costs	'
	Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred in the three and nine months ended September 30, 2012 ($ amounts in thousands, except per share/unit data).
		For the Three Months Ended							For the Nine Months Ended
		September 30,							September 30,
		2013			2012				2013				2012
	Total revenues	$	65,518		$	63,695			$	196,708			$	188,339
	Net income		29,366			37,091				89,570				92,620
	Net income per share/unit — diluted	$	0.18		$	0.25			$	0.55			$	0.63
Summary of Status Update on Current Development Projects	'
	See table below for a status update on our current development projects (in thousands):
	Property	Location		Property Type	Operator		Original				Costs				Estimated
							Commitment				Incurred as				Completion
											of September 30,				Date
											2013
	Victoria Rehabilitation Hospital	Victoria, TX		Long-term Acute	Post Acute Medical		$	9,400			$	8,391				4th Qtr 2013
				Care Hospital
	First Choice ER — Brodie	Austin, TX		General Acute	First Choice			5,470				1,509				1st Qtr 2014
				Care Hospital
	First Choice ER — Little Elm	Dallas, TX		General Acute	First Choice			5,200				2,792				4th Qtr 2013
				Care Hospital
	Rehabilitation Hospital of the Northwest	Post Falls, ID		Rehabilitation	Ernest Health, Inc.			14,387				10,389				4th Qtr 2013
				Hospital
	Oakleaf Surgical Hospital	Altoona, WI		General Acute	National Surgical			33,500				11,146				3rd Qtr 2014
				Care Hospital	Hospitals
	Northern Utah Rehabilitation Hospital	South Ogden, UT		Rehabilitation	Ernest Health, Inc.			19,153				7,406				3rd Qtr 2014
				Hospital
	First Choice Emergency Rooms	Various		General Acute	First Choice			89,330				—				Various
				Care Hospital
							$	176,440			$	41,633
Components of Net Investment in Direct Financing Leases	'
	The components of our net investment in DFL consisted of the following (dollars in thousands):
		As of September 30,			As of December 31,
		2013			2012
	Minimum lease payments receivable	$	1,566,155		$	1,277,923
	Estimated residual values		211,283			201,283
	Less: Unearned income		(1,373,926	)		(1,164,794	)
	Net investment in direct financing leases	$	403,512		$	314,412
Summary of Loans	'
	The following is a summary of our loans (in thousands):
		As of			As of
		September 30,			December 31,
		2013			2012
	Mortgage loans	$	368,650		$	368,650
	Acquisition loans		103,516			98,433
	Working capital and other loans		54,377			57,458
	Convertible loan		3,352			3,352
		$	529,895		$	527,893

Debt_Tables

Debt (Tables)	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Summary of Debt, Net of Discounts	'
	The following is a summary of debt, net of discounts (dollar amounts in thousands):
			As of September 30,					As of December 31,
			2013					2012
			Balance		Interest Rate			Balance			Interest Rate
	Revolving credit facility		$	45,000		Variable		$	125,000			Variable
	2006 Senior Unsecured Notes			125,000		Various			125,000			Various
	2011 Senior Unsecured Notes			450,000		6.875	%		450,000			6.875	%
	2012 Senior Unsecured Notes:
	Principal amount			350,000		6.375	%		200,000			6.375	%
	Unamortized premium			2,960					—			—
				352,960					200,000
	Exchangeable senior notes:
	Principal amount (A)			—		N/A			11,000			9.25	%
	Unamortized discount			—					(37	)
				—					10,963
	Term loans			114,013		Various			114,197			Various
			$	1,086,973				$	1,025,160
Principal Payments Due for Debt	'
	As of September 30, 2013, principal payments due for our debt (which exclude the effects of any discounts or premiums recorded) are as follows (in thousands):
	2013		$	64
	2014			266
	2015			45,283
	2016			225,299
	2017			320
	Thereafter			812,781
	Total		$	1,084,013
	(A)	The exchangeable senior notes were paid in full on April 1, 2013.

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Summary of Fair Value Information of Financial Instruments	'
	The following table summarizes fair value estimates for our financial instruments (in thousands):
			September 30,						December 31,
			2013						2012
	Asset (Liability)		Book			Fair			Book			Fair
			Value			Value			Value			Value
	Interest and rent receivables		$	54,505		$	43,723		$	45,289		$	36,700
	Loans (1)			331,612			329,367			334,693			335,595
	Debt, net			(1,086,973	)		(1,116,389	)		(1,025,160	)		(1,082,333	)
	-1	Excludes loans related to the Ernest Transaction since they are recorded at fair value and discussed below.
Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis	'
	At September 30, 2013, these amounts were as follows (in thousands):
	Asset Type		Fair			Cost			Asset Type
			Value						Classification
	Mortgage loans		$	100,000		$	100,000			Mortgage loans
	Acquisition loan			98,283			98,283			Other loans
	Equity investments			3,300			3,300			Other assets
			$	201,583		$	201,583
Summary Showing Sensitivity Analysis by Using Basis Point Variations	'
	To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):
	Basis Point		Estimated Increase (Decrease)
			In Fair Value
	Change in
	Marketability Discount
	+100 basis points		$	(300	)
	- 100 basis points			300

Discontinued_Operations_Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2013
Discontinued Operations And Disposal Groups [Abstract]	'
Discontinued Operations	'
	The following table presents the results of discontinued operations, for the three and nine months ended September 30, 2013 and 2012 (dollar amounts in thousands except per share/unit amounts):
		For the Three Months				For the Nine Months
		Ended September 30,				Ended September 30,
		2013		2012		2013		2012
	Revenues	$	37	$	460	$	568	$	5,919
	Gain (loss) on sale		—		8,726		2,054		7,280
	Income		37		8,643		2,498		11,050
	Earnings per share/unit — diluted	$	—	$	0.06	$	0.02	$	0.08

Earnings_Per_ShareCommon_Unit_

Earnings Per Share/Common Unit (Tables)	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Calculation of Earnings Per Share	'
	Medical Properties Trust, Inc.
	Our earnings per share were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	25,666		$	22,865
	Non-controlling interests’ share in continuing operations		(55	)		(44	)
	Participating securities’ share in earnings		(166	)		(225	)
	Income from continuing operations, less participating securities’ share in earnings		25,445			22,596
	Income from discontinued operations attributable to MPT common stockholders		37			8,643
	Net income, less participating securities’ share in earnings	$	25,482		$	31,239
	Denominator:
	Basic weighted-average common shares		154,758			134,781
	Dilutive potential common shares		1,211			1
	Dilutive weighted-average common shares		155,969			134,782
		For the Nine Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	76,819		$	50,424
	Non-controlling interests’ share in continuing operations		(165	)		(130	)
	Participating securities’ share in earnings		(538	)		(715	)
	Income from continuing operations, less participating securities’ share in earnings		76,116			49,579
	Income from discontinued operations attributable to MPT common stockholders		2,498			11,050
	Net income, less participating securities’ share in earnings	$	78,614		$	60,629
	Denominator:
	Basic weighted-average common shares		148,204			131,467
	Dilutive potential common shares		1,313			—
	Dilutive weighted-average common shares		149,517			131,467
	MPT Operating Partnership, L.P.
	Our earnings per common unit were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	25,666		$	22,865
	Non-controlling interests’ share in continuing operations		(55	)		(44	)
	Participating securities’ share in earnings		(166	)		(225	)
	Income from continuing operations, less participating securities’ share in earnings		25,445			22,596
	Income from discontinued operations attributable to MPT Operating Partnership partners		37			8,643
	Net income, less participating securities’ share in earnings	$	25,482		$	31,239
	Denominator:
	Basic weighted-average units		154,758			134,781
	Dilutive potential units		1,211			1
	Dilutive weighted-average units		155,969			134,782
		For the Nine Months
		Ended September 30,
		2013			2012
	Numerator:
	Income from continuing operations	$	76,819		$	50,424
	Non-controlling interests’ share in continuing operations		(165	)		(130	)
	Participating securities’ share in earnings		(538	)		(715	)
	Income from continuing operations, less participating securities’ share in earnings		76,116			49,579
	Income from discontinued operations attributable to MPT Operating Partnership partners		2,498			11,050
	Net income, less participating securities’ share in earnings	$	78,614		$	60,629
	Denominator:
	Basic weighted-average units		148,204			131,467
	Dilutive potential units		1,313			—
	Dilutive weighted-average units		149,517			131,467

Condensed_Consolidating_Financ1

Condensed Consolidating Financial Information (Tables)	9 Months Ended
	Sep. 30, 2013
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]	'
Condensed Consolidated Balance Sheet	'
	Condensed Consolidated Balance Sheet
	September 30, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Assets
	Real estate assets
	Land, buildings and improvements and intangible lease assets	$	—		$	—		$	1,259,234		$	347,198		$	—		$	1,606,432
	Mortgage loans		—			—			268,650			100,000			—			368,650
	Net investment in direct financing leases		—			—			186,586			216,926			—			403,512
	Gross investment in real estate assets		—			—			1,714,470			664,124			—			2,378,594
	Accumulated depreciation and amortization		—			—			(142,939	)		(7,727	)		—			(150,666	)
	Net investment in real estate assets		—			—			1,571,531			656,397			—			2,227,928
	Cash and cash equivalents		—			11,391			—			733			—			12,124
	Interest and rent receivable		—			715			29,284			24,506			—			54,505
	Straight-line rent receivable		—			—			36,051			8,189			—			44,240
	Other loans		—			178			—			161,067			—			161,245
	Net intercompany receivable		32,053			1,639,081			—			—			(1,671,134	)		—
	Investment in subsidiaries		1,358,959			783,441			43,557			—			(2,185,957	)		—
	Other assets		—			32,534			980			29,594			—			63,108
	Total Assets	$	1,391,012		$	2,467,340		$	1,681,403		$	880,486		$	(3,857,091	)	$	2,563,150
	Liabilities and Equity
	Liabilities
	Debt, net	$	—		$	1,072,960		$	—		$	14,013		$	—		$	1,086,973
	Accounts payable and accrued expenses		32,443			35,705			4,935			769			—			73,852
	Net intercompany payable		—			—			998,987			672,147			(1,671,134	)		—
	Deferred revenue		—			(284	)		17,970			5,543			—			23,229
	Lease deposits and other obligations to tenants		—			—			17,923			2,604			—			20,527
	Total liabilities		32,443			1,108,381			1,039,815			695,076			(1,671,134	)		1,204,581
	Total equity		1,358,569			1,358,959			641,588			185,410			(2,185,957	)		1,358,569
	Total Liabilities and Equity	$	1,391,012		$	2,467,340		$	1,681,403		$	880,486		$	(3,857,091	)	$	2,563,150
	Condensed Consolidated Balance Sheet
	December 31, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Assets
	Real estate assets
	Land, buildings and improvements and intangible lease assets	$	—		$	28		$	1,196,124		$	65,947		$	—		$	1,262,099
	Real estate held for sale		—			—			—			16,497			—			16,497
	Mortgage loans		—			—			268,650			100,000			—			368,650
	Investment in direct financing leases		—			—			110,155			204,257			—			314,412
	Gross investment in real estate assets		—			28			1,574,929			386,701			—			1,961,658
	Accumulated depreciation and amortization		—			—			(118,163	)		(6,452	)		—			(124,615	)
	Net investment in real estate assets		—			28			1,456,766			380,249			—			1,837,043
	Cash and cash equivalents		—			35,483			1,565			263			—			37,311
	Interest and rent receivable		—			212			29,159			15,918			—			45,289
	Straight-line rent receivable		—			—			29,314			6,546			—			35,860
	Other loans		—			177			—			159,066			—			159,243
	Net intercompany receivable		27,393			1,373,941			—			—			(1,401,334	)		—
	Investment in subsidiaries		1,050,204			647,029			42,666			—			(1,739,899	)		—
	Other assets		—			31,097			1,522			31,521			—			64,140
	Total Assets	$	1,077,597		$	2,087,967		$	1,560,992		$	593,563		$	(3,141,233	)	$	2,178,886
	Liabilities and Equity
	Liabilities
	Debt, net	$	—		$	1,010,962		$	—		$	14,198		$	—		$	1,025,160
	Accounts payable and accrued expenses		27,783			26,658			10,492			1,028			—			65,961
	Net intercompany payable		—			—			1,000,117			401,217			(1,401,334	)		—
	Deferred revenue		—			143			19,621			845			—			20,609
	Lease deposits and other obligations to tenants		—			—			16,606			736			—			17,342
	Total liabilities		27,783			1,037,763			1,046,836			418,024			(1,401,334	)		1,129,072
	Total equity		1,049,814			1,050,204			514,156			175,539			(1,739,899	)		1,049,814
	Total Liabilities and Equity	$	1,077,597		$	2,087,967		$	1,560,992		$	593,563		$	(3,141,233	)	$	2,178,886
Condensed Consolidated Statements of Income	'
	Condensed Consolidated Statements of Income
	For the Three Months Ended September 30, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Revenues
	Rent billed	$	—		$	—		$	29,770		$	5,403		$	(3,295	)	$	31,878
	Straight-line rent		—			—			2,189			664			—			2,853
	Income from direct financing leases		—			—			10,519			5,750			(4,971	)		11,298
	Interest and fee income		—			5,004			9,161			7,299			(7,037	)		14,427
	Total revenues		—			5,004			51,639			19,116			(15,303	)		60,456
	Expenses
	Real estate depreciation and amortization		—			—			8,363			426			—			8,789
	Property-related		—			182			251			8,291			(8,266	)		458
	General and administrative		—			6,867			—			(487	)		—			6,380
	Acquisition expenses		—			4,179			—			—			—			4,179
	Total operating expenses		—			11,228			8,614			8,230			(8,266	)		19,806
	Operating income (expense)		—			(6,224	)		43,025			10,886			(7,037	)		40,650
	Other income (expense)
	Other income (expense)		—			5			—			(2	)		—			3
	Earnings from equity and other interests		—			—			454			389			—			843
	Interest income (expense)		—			(16,055	)		454			(7,266	)		7,037			(15,830	)
	Net other income (expense)		—			(16,050	)		908			(6,879	)		7,037			(14,984	)
	Income (loss) from continuing operations		—			(22,274	)		43,933			4,007			—			25,666
	Income from discontinued operations		—			—			—			37			—			37
	Equity in earnings of consolidated subsidiaries, net of income taxes		25,703			47,977			1,114			—			(74,794	)		—
	Net income		25,703			25,703			45,047			4,044			(74,794	)		25,703
	Net income (loss) attributable to non-controlling interests		(55	)		(55	)		—			—			55			(55	)
	Net income attributable to MPT common stockholders	$	25,648		$	25,648		$	45,047		$	4,044		$	(74,739	)	$	25,648
	Condensed Consolidated Statements of Income
	For the Nine Months Ended September 30, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Revenues
	Rent billed	$	—		$	—		$	89,149		$	14,970		$	(9,045	)	$	95,074
	Straight-line rent		—			—			6,617			1,643			—			8,260
	Income from direct financing leases		—			—			27,387			16,744			(14,847	)		29,284
	Interest and fee income		—			15,112			27,565			21,816			(21,211	)		43,282
	Total revenues		—			15,112			150,718			55,173			(45,103	)		175,900
	Expenses
	Real estate depreciation and amortization		—			—			24,775			1,276			—			26,051
	Property-related		—			458			792			24,162			(23,892	)		1,520
	General and administrative		—			21,286			—			137			—			21,423
	Acquisition expenses		—			6,457			—			—			—			6,457
	Total operating expenses		—			28,201			25,567			25,575			(23,892	)		55,451
	Operating income (expense)		—			(13,089	)		125,151			29,598			(21,211	)		120,449
	Other income (expense)
	Other income (expense)		—			(37	)		—			(208	)		—			(245	)
	Earnings from equity and other interests		—			—			687			1,824			—			2,511
	Interest income (expense)		—			(46,298	)		1,083			(21,892	)		21,211			(45,896	)
	Net other income (expense)		—			(46,335	)		1,770			(20,276	)		21,211			(43,630	)
	Income (loss) from continuing operations		—			(59,424	)		126,921			9,322			—			76,819
	Income from discontinued operations		—			—			(4	)		2,502			—			2,498
	Equity in earnings of consolidated subsidiaries net of income taxes		79,317			138,741			3,356			—			(221,414	)		—
	Net income		79,317			79,317			130,273			11,824			(221,414	)		79,317
	Net income (loss) attributable to non-controlling interests		(165	)		(165	)		—			—			165			(165	)
	Net income attributable to MPT common stockholders	$	79,152		$	79,152		$	130,273		$	11,824		$	(221,249	)	$	79,152
	Condensed Consolidated Statements of Income
	For the Three Months Ended September 30, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed	$	—		$	—		$	28,470		$	4,163		$	(2,335	)	$	30,298
Straight-line rent		—			—			2,371			374			—			2,745
Income from direct financing leases		—			—			5,238			5,394			(4,859	)		5,773
Interest and fee income		—			5,242			8,917			6,943			(7,065	)		14,037
Total revenues		—			5,242			44,996			16,874			(14,259	)		52,853
Expenses
Real estate depreciation and amortization		—			—			7,883			425			—			8,308
Property-related		—			88			116			7,204			(7,194	)		214
General and administrative		—			6,332			—			720			—			7,052
Acquisition expenses		—			410			—			—			—			410
Total operating expenses		—			6,830			7,999			8,349			(7,194	)		15,984
Operating income (loss)		—			(1,588	)		36,997			8,525			(7,065	)		36,869
Other income (expense)
Other income (expense)		—			(21	)		(2	)		—			—			(23	)
Earnings from equity and other interests		—			—			331			734			—			1,065
Interest income (expense)		—			(15,203	)		388			(7,296	)		7,065			(15,046	)
Net other income (expense)		—			(15,224	)		717			(6,562	)		7,065			(14,004	)
Income (loss) from continuing operations		—			(16,812	)		37,714			1,963			—			22,865
Income (loss) from discontinued operations		—			—			314			8,329			—			8,643
Equity in earnings of consolidated subsidiaries, net of income taxes		31,508			48,320			1,129			—			(80,957	)		—
Net income		31,508			31,508			39,157			10,292			(80,957	)		31,508
Net income (loss) attributable to non-controlling interests		(44	)		(44	)		—			—			44			(44	)
Net income attributable to MPT common stockholders	$	31,464		$	31,464		$	39,157		$	10,292		$	(80,913	)	$	31,464
Condensed Consolidated Statements of Income
For the Nine Months Ended September 30, 2012
(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed	$	—		$	—		$	85,160		$	12,446		$	(6,926	)	$	90,680
Straight-line rent		—			—			4,310			1,119			—			5,429
Income from direct financing leases		—			—			11,730			12,600			(11,351	)		12,979
Interest and fee income		—			13,219			20,620			17,358			(17,711	)		33,486
Total revenues		—			13,219			121,820			43,523			(35,988	)		142,574
Expenses
Real estate depreciation and amortization		—			—			23,551			1,275			—			24,826
Property-related		—			349			580			18,375			(18,277	)		1,027
General and administrative		—			20,067			—			1,274			—			21,341
Acquisition expenses		—			4,115			—			—			—			4,115
Total operating expenses		—			24,531			24,131			20,924			(18,277	)		51,309
Operating income (loss)		—			(11,312	)		97,689			22,599			(17,711	)		91,265
Other income (expense)
Other income (expense)		—			(49	)		(2	)		(4	)		—			(55	)
Earnings from equity and other interests		—			—			783			1,161			—			1,944
Interest income (expense)		—			(42,905	)		867			(18,403	)		17,711			(42,730	)
Net other income (expense)		—			(42,954	)		1,648			(17,246	)		17,711			(40,841	)
Income (loss) from continuing operations		—			(54,266	)		99,337			5,353			—			50,424
Income (loss) from discontinued operations		—			—			106			10,944			—			11,050
Equity in earnings of consolidated subsidiaries net of income taxes		61,474			115,740			3,367			—			(180,581	)		—
Net income		61,474			61,474			102,810			16,297			(180,581	)		61,474
Net income (loss) attributable to non-controlling interests		(130	)		(130	)		—			—			130			(130	)
Net income attributable to MPT common stockholders	$	61,344		$	61,344		$	102,810		$	16,297		$	(180,451	)	$	61,344
Condensed Consolidated Statements of Comprehensive Income (Loss)	'
	Condensed Consolidated Statements of Comprehensive Income
	For the Three Months Ended September 30, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Net income	$	25,703		$	25,703		$	45,047		$	4,044		$	(74,794	)	$	25,703
	Other comprehensive income:
	Unrealized gain on interest rate swap		182			182			—			—			(182	)		182
	Total comprehensive income		25,885			25,885			45,047			4,044			(74,976	)		25,885
	Comprehensive income attributable to non-controlling interests		(55	)		(55	)		—			—			55			(55	)
	Comprehensive income attributable to MPT common stockholders	$	25,830		$	25,830		$	45,047		$	4,044		$	(74,921	)	$	25,830
	Condensed Consolidated Statements of Comprehensive Income
	For the Nine Months Ended September 30, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Net income	$	79,317		$	79,317		$	130,273		$	11,824		$	(221,414	)	$	79,317
	Other comprehensive income:
	Unrealized gain on interest rate swap		2,788			2,788			—			—			(2,788	)		2,788
	Total comprehensive income		82,105			82,105			130,273			11,824			(224,202	)		82,105
	Comprehensive income attributable to non-controlling interests		(165	)		(165	)		—			—			165			(165	)
	Comprehensive income attributable to MPT common stockholders	$	81,940		$	81,940		$	130,273		$	11,824		$	(224,037	)	$	81,940
	Condensed Consolidated Statements of Comprehensive Income
	For the Three Months Ended September 30, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Net income	$	31,508		$	31,508		$	39,157		$	10,292		$	(80,957	)	$	31,508
	Other comprehensive income (loss):
	Unrealized loss on interest rate swap		(443	)		(443	)		—			—			443			(443	)
	Total comprehensive income		31,065			31,065			39,157			10,292			(80,514	)		31,065
	Comprehensive income attributable to non-controlling interests		(44	)		(44	)		—			—			44			(44	)
	Comprehensive income attributable to MPT common stockholders	$	31,021		$	31,021		$	39,157		$	10,292		$	(80,470	)	$	31,021
	Condensed Consolidated Statements of Comprehensive Income
	For the Nine Months Ended September, 30, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Net income	$	61,474		$	61,474		$	102,810		$	16,297		$	(180,581	)	$	61,474
	Other comprehensive income (loss):
	Unrealized loss on interest rate swap		(989	)		(989	)		—			—			989			(989	)
	Total comprehensive income		60,485			60,485			102,810			16,297			(179,592	)		60,485
	Comprehensive income attributable to non-controlling interests		(130	)		(130	)		—			—			130			(130	)
	Comprehensive income attributable to MPT common stockholders	$	60,355		$	60,355		$	102,810		$	16,297		$	(179,462	)	$	60,355
Condensed Consolidated Statements of Cash Flows	'
	Condensed Consolidated Statements of Cash Flows
	For the Nine Months Ended September 30, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Operating Activities
	Net cash provided by (used in) operating activities	$	91		$	(38,891	)	$	156,913		$	(16,549	)	$	—		$	101,564
	Investing Activities
	Cash paid for acquisitions and other related investments		—			—			(95,000	)		(276,500	)		—			(371,500	)
	Principal received on loans receivable		—			—			—			4,694			—			4,694
	Net proceeds from sale of real estate		—			—			—			18,409			—			18,409
	Investments in and advances to subsidiaries		(225,683	)		(267,545	)		(1,506	)		269,142			225,592			—
	Investments in loans receivable		—			—			—			(1,445	)		—			(1,445	)
	Construction in progress and other		—			(765	)		(63,691	)		1,034			—			(63,422	)
	Net cash provided by (used in) investing activities		(225,683	)		(268,310	)		(160,197	)		15,334			225,592			(413,264	)
	Financing Activities
	Revolving credit facilities, net		—			(80,000	)		—			—			—			(80,000	)
	Additions to term debt, net of discount		—			153,000			—			—			—			153,000
	Payments of term debt		—			(11,000	)		—			(185	)		—			(11,185	)
	Distributions paid		(87,727	)		(87,928	)		—			—			87,727			(87,928	)
	Proceeds from sale of common shares/units, net of offering costs		313,319			313,319			—			—			(313,319	)		313,319
	Lease deposits and other obligations to tenants		—			—			1,719			1,870			—			3,589
	Debt issuance costs paid and other financing activities		—			(4,282	)		—			—			—			(4,282	)
	Net cash provided by financing activities		225,592			283,109			1,719			1,685			(225,592	)		286,513
	Increase (decrease) in cash and cash equivalents for period		—			(24,092	)		(1,565	)		470			—			(25,187	)
	Cash and cash equivalents at beginning of period		—			35,483			1,565			263			—			37,311
	Cash and cash equivalents at end of period	$	—		$	11,391		$	—		$	733		$	—		$	12,124
	Condensed Consolidated Statements of Cash Flows
	For the Nine Months Ended September 30, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Operating Activities
	Net cash provided by (used in) operating activities	$	16		$	(38,780	)	$	109,018		$	4,455		$	—		$	74,709
	Investing Activities
	Cash paid for acquisitions and other related investments		—			—			(410,000	)		(196,500	)		—			(606,500	)
	Principal received on loans receivable		—			—			5,491			4,016			—			9,507
	Net proceeds from sale of real estate		—			—			800			33,300			—			34,100
	Investments in and advances to subsidiaries		(143,554	)		(540,016	)		380,605			159,427			143,538			—
	Investments in loans receivable		—			—			—			(1,293	)		—			(1,293	)
	Construction in progress and other		—			(59	)		(33,869	)		(1,992	)		—			(35,920	)
	Net cash used in investing activities		(143,554	)		(540,075	)		(56,973	)		(3,042	)		143,538			(600,106	)
	Financing Activities
	Revolving credit facilities, net		—			75,000			(39,600	)		—			—			35,400
	Additions to term debt		—			300,000			—			—			—			300,000
	Payments of term debt		—			—			—			(171	)		—			(171	)
	Distributions paid		(76,569	)		(76,770	)		—			—			76,569			(76,770	)
	Proceeds from sale of common stock/units, net of offering costs		220,107			220,107			—			—			(220,107	)		220,107
	Lease deposits and other obligations to tenants		—			—			(12,289	)		(1,102	)		—			(13,391	)
	Debt issuance costs paid and other financing activities		—			(6,341	)		—			—			—			(6,341	)
	Net cash provided by (used in) financing activities		143,538			511,996			(51,889	)		(1,273	)		(143,538	)		458,834
	Increase in cash and cash equivalents for period		—			(66,859	)		156			140			—			(66,563	)
	Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726
	Cash and cash equivalents at end of period	$	—		$	34,371		$	1,565		$	227		$	—		$	36,163

Carrying_Value_and_Classificat

Carrying Value and Classification of Related Assets and Maximum Exposure to Loss as Result of Involvement with Variable Interest Entities (Detail) (USD $)	Sep. 30, 2013
In Thousands, unless otherwise specified
Mortgage and other loans	'
Variable Interest Entity [Line Items]	'
Carrying Amount	$229,646	[1]
Other assets	'
Variable Interest Entity [Line Items]	'
Carrying Amount	5,079	[1]
Loans, net	'
Variable Interest Entity [Line Items]	'
Maximum Loss Exposure	283,157	[2]
Equity investments	'
Variable Interest Entity [Line Items]	'
Maximum Loss Exposure	$19,519	[2]
[1]	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
[2]	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rent receivables), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.

Real_Estate_and_Lending_Activi2

Real Estate and Lending Activities - Additional Information (Detail) (USD $)

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

3 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

Sep. 13, 2013

Jul. 18, 2013

Jun. 11, 2013

Jul. 03, 2012

Mar. 31, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

4-May-13

Sep. 30, 2013

Oct. 14, 2011

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 18, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 18, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 19, 2012

Sep. 19, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 03, 2012

Sep. 13, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Jun. 13, 2013

Feb. 29, 2012

Sep. 30, 2013

Sep. 30, 2013

Mar. 31, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Jul. 18, 2013

Jul. 18, 2013

20-May-13

Sep. 30, 2013

Mar. 04, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2010

Jul. 11, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 30, 2012

Sep. 30, 2013

Apr. 30, 2013

Jun. 15, 2012

Aug. 21, 2012

Sep. 28, 2012

Hospital

Leases

Contract

Contract

Bed

Letter of Credit

Emerus Holding, Inc. and Baptist Health System JV

Emerus Holding, Inc. and Baptist Health System JV

Emerus Holding, Inc. and Baptist Health System JV

Twelve Oaks Facility

Texas

California

Minimum

Minimum

Minimum

Minimum

Maximum

Maximum

Maximum

Maximum

Acute Care Medical Center

Roxborough Memorial Hospital

2013 Acquisitions [Member]

2013 Acquisitions [Member]

Acute Care Iasis Hospital

Acute Care Iasis Hospital

Acute Care Facility

Acute Care Facility

Rehabilitation Hospital

Rehabilitation Hospital

Ernest

Ernest

Ernest

Ernest

Ernest

Ernest

Ernest

Ernest

Ernest

Florence acute care facility

Prime Health Care Services

Prime Health Care Services

Prime Health Care Services

Prime Health Care Services

Prime Health Care Services

Corpus Christi Rehabilitation Hospital

Corpus Christi Rehabilitation Hospital

Rehabilitation Facility in South Ogden

Rehabilitation Facility in South Ogden

Rehabilitation Facility in Post Falls, Idaho

Rehabilitation Facility in Post Falls, Idaho

Monroe Hospital

Monroe Hospital

First Choice

Location Dallas, TX [Member]

Location Austin, TX

Location Altoona, WI

Location Altoona, WI

Health South Rehabilitation Hospital Of Southeast Arizona and Southeast Texas

HealthSouth Rehabilitation Hospital of Fayetteville

Denham Springs

Thornton

RenewalOptions

Hospital

Property

Property

Emerus Holding, Inc. and Baptist Health System JV

Floor Rate [Member]

Emerus Holding, Inc. and Baptist Health System JV

Ceiling [Member]

Bed

Bed

Facility

Maximum

Facility

Bed

Facility

Facility

Bed

Key Management Personnel

Minimum

Commitment

Room

Hospital

Bed

Contract

State

Significant Acquisitions and Disposals [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

General acute care hospitals acquired

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

7

'

11

5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition costs

'

'

'

'

'

$4,179,000

$410,000

$6,457,000

$4,115,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$80,000,000

$30,000,000

'

'

$283,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Improvement costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Initial leaseback term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'15 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum rent increase percent

'

'

2.00%

'

'

'

'

9.00%

'

'

'

'

'

'

'

'

'

2.00%

0.50%

'

2.00%

5.00%

2.00%

'

5.00%

'

'

'

'

'

2.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Lease renewal option

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Lease maturity year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2019

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Extended lease maturity year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2028

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase price of acquisition

'

'

75,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

96,500,000

'

96,500,000

'

'

'

'

'

'

'

'

'

'

'

'

15,800,000

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term of lease

'27 years

'

'10 years

'

'

'

'

'20 years

'

'

'

'

'15 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'20 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term of lease extension, years

'

'5 years

'5 years

'

'

'

'

'5 years

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of lease extension options in current lease contract

'

'

2

'

'

3

'

3

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of beds

'

'

'

'

'

'

'

'

'

26

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

380

140

'

'

'

'

'

369

'

'

'

'

'

'

'

40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Mortgage loan funded

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Combined purchase price and investment amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

396,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of states

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate purchase price

'

'

'

'

'

'

'

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loan secured by mortgage interest

'

'

'

'

'

100,000,000

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition loan made

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

93,200,000

'

93,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Capital contribution

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate on acquisition loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Coupon payable in cash, year one

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Coupon payable in cash, year two

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Coupon payable in cash in, thereafter

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Agreement terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Although there are provisions in the loan agreement that are expected to result in full payment of the 15% preference when funds are sufficient. Any of the 15% in excess of the minimum that is not paid may be accrued and paid upon the occurrence of a capital or liquidity event and is payable at maturity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenue from business acquisitions

'

'

'

'

'

2,900,000

'

3,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition related costs

'

'

'

'

'

4,179,000

410,000

6,457,000

4,115,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,600,000

1,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of freestanding emergency room facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25

'

'

'

'

'

'

'

'

Estimated total development cost, funded

'

'

'

'

'

4,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,400,000

'

10,400,000

'

'

100,000,000

'

'

'

11,100,000

'

'

'

'

Estimated cost of the new facility

'

'

'

'

'

'

'

9,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

19,200,000

'

14,400,000

'

'

'

'

5,200,000

5,500,000

33,500,000

'

'

'

'

'

Facility partially occupied date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

23-Jan-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of facility partially occupied

'

'

'

'

'

'

'

'

'

'

'

'

'

'

55.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Lease agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'15 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cost incurred in new facility

'

'

'

'

'

8,400,000

'

8,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,000,000

'

15,000,000

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

initial lease term

'

'

'

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'20 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of leased hospital

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business acquisition cost of acquired entity

'

'

'

'

'

'

'

'

'

'

'

30,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Rent escalations percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

3.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of properties completed

'

'

'

'

'

'

'

'

'

'

'

'

2

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of real estate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,500,000

16,000,000

5,200,000

17,400,000

Gain (loss) on sale of real estate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,100,000

-1,400,000

300,000

8,400,000

Number of hospitals sold

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

'

'

'

Increase in consumer price index

'

'

'

100.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of lease renewal options

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Lease advance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

29,900,000

'

'

'

'

'

'

'

'

'

'

Operating leases rent, interest and other charges outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21,000,000

'

'

'

'

'

'

'

'

'

'

Interest receivables

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,000,000

'

'

'

'

'

'

'

'

'

'

Impairment of working capital loan recognized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,000,000

'

'

'

'

'

'

'

'

'

Straight line rent receivables write-off

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,500,000

'

'

'

'

'

'

'

'

'

Number of days past due

'90 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'90 days

'

'

'

'

'

'

'

'

'

'

Net investment to maximum exposure

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

39,000,000

'

'

'

'

'

'

'

'

'

'

Impairment of working capital loan estimation-patient receivables considered for first priority secured interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,000,000

'

'

'

'

'

'

'

'

'

'

Impairment of working capital loan estimation-cash balance considered for first priority secured interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

Rent receivables

'

'

'

'

'

500,000

'

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Letter of credit outstanding

'

'

'

'

'

'

'

'

'

'

1,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount of convertible note converted into equity interest

'

'

'

'

1,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible note

'

'

'

'

5,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of equity shares from convertible debt

'

'

'

'

9.90%

15.10%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Remaining convertible debt after conversion of part of debt

'

'

'

'

'

$3,300,000

'

$3,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of entity revenue from affiliates

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20.70%

21.10%

20.50%

18.40%

'

'

'

'

'

'

33.70%

28.70%

32.40%

26.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of total assets accounted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

24.50%

20.40%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17.40%

'

'

'

18.20%

'

'

'

'

'

26.70%

'

'

'

27.90%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum percentage of entity's total assets invested on single property

'

'

'

'

'

5.00%

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Real_Estate_and_Lending_Activi3

Real Estate and Lending Activities - Assets Acquired (Detail) (Ernest, USD $)	Feb. 28, 2013	Feb. 29, 2012
In Thousands, unless otherwise specified
Significant Acquisitions and Disposals [Line Items]	'	'
Total assets acquired	$371,500	$606,500
Land	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Total assets acquired	16,220	'
Building	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Total assets acquired	265,030	'
Net investments in direct financing leases	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Total assets acquired	85,000	310,000
Mortgage loans	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Total assets acquired	'	200,000
Other loans	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Total assets acquired	5,250	93,200
Equity investments	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Total assets acquired	'	$3,300

Real_Estate_and_Lending_Activi4

Real Estate and Lending Activities - Supplemental Pro Forma Earnings Adjusted to Exclude Acquisition-Related Costs (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Business Combinations [Abstract]	'	'	'	'
Total revenues	$65,518	$63,695	$196,708	$188,339
Net income	$29,366	$37,091	$89,570	$92,620
Net income per share/unit - diluted	$0.18	$0.25	$0.55	$0.63

Real_Estate_and_Lending_Activi5

Real Estate and Lending Activities - Summary of Status Update on Current Development Projects (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013
Business Acquisition [Line Items]	'
Original Commitment	$176,440
Costs Incurred as of September 30, 2013	41,633
Property Victoria Rehabilitation Hospital | Location Victoria, TX | Property Type Long-term Acute Care Hospital | Operator Post Acute Medical	'
Business Acquisition [Line Items]	'
Original Commitment	9,400
Costs Incurred as of September 30, 2013	8,391
Estimated Completion Date	'4th Qtr 2013
Property First Choice ER - Brodie | Location Austin, TX | Property Type General Acute Care Hospital | Operator First Choice	'
Business Acquisition [Line Items]	'
Original Commitment	5,470
Costs Incurred as of September 30, 2013	1,509
Estimated Completion Date	'1st Qtr 2014
Property First Choice ER - Little Elm | Location Dallas, TX [Member] | Property Type General Acute Care Hospital | Operator First Choice	'
Business Acquisition [Line Items]	'
Original Commitment	5,200
Costs Incurred as of September 30, 2013	2,792
Estimated Completion Date	'4th Qtr 2013
Property Rehabilitation Hospital of the Northwest | Location Post Falls, ID | Property Type Rehabilitation Hospital | Operator Ernest Health, Inc.	'
Business Acquisition [Line Items]	'
Original Commitment	14,387
Costs Incurred as of September 30, 2013	10,389
Estimated Completion Date	'4th Qtr 2013
Property Oakleaf Surgical Hospital | Location Altoona, WI | Property Type General Acute Care Hospital | Operator National Surgical Hospitals	'
Business Acquisition [Line Items]	'
Original Commitment	33,500
Costs Incurred as of September 30, 2013	11,146
Estimated Completion Date	'3rd Qtr 2014
Property Northern Utah Rehabilitation Hospital | Location South Ogden, UT | Property Type Rehabilitation Hospital | Operator Ernest Health, Inc.	'
Business Acquisition [Line Items]	'
Original Commitment	19,153
Costs Incurred as of September 30, 2013	7,406
Estimated Completion Date	'3rd Qtr 2014
Property First Choice Emergency Rooms | Location Various | Property Type General Acute Care Hospital | Operator First Choice	'
Business Acquisition [Line Items]	'
Original Commitment	$89,330
Estimated Completion Date	'Various

Real_Estate_and_Lending_Activi6

Real Estate and Lending Activities - Components of Net Investment in Direct Financing Leases (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Business Combinations [Abstract]	'	'
Minimum lease payments receivable	$1,566,155	$1,277,923
Estimated residual values	211,283	201,283
Less: Unearned income	-1,373,926	-1,164,794
Net investment in direct financing leases	$403,512	$314,412

Real_Estate_and_Lending_Activi7

Real Estate and Lending Activities - Summary of Loans (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Loans [Line Items]	'	'
Loans Receivable Net	$529,895	$527,893
Mortgage loans	'	'
Loans [Line Items]	'	'
Loans Receivable Net	368,650	368,650
Acquisition loans	'	'
Loans [Line Items]	'	'
Loans Receivable Net	103,516	98,433
Working capital and other loans	'	'
Loans [Line Items]	'	'
Loans Receivable Net	54,377	57,458
Convertible loan	'	'
Loans [Line Items]	'	'
Loans Receivable Net	$3,352	$3,352

Debt_Summary_of_Debt_Net_of_Di

Debt - Summary of Debt Net of Discounts (Detail) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Long term debt	$1,086,973	$1,025,160
Revolving credit facility	'	'
Debt Instrument [Line Items]	'	'
Interest rate	'Variable	'Variable
Principal amount	45,000	125,000
2006 Senior Unsecured Notes	'	'
Debt Instrument [Line Items]	'	'
Interest rate	'Various	'Various
Principal amount	125,000	125,000
2011 Senior Unsecured Notes	'	'
Debt Instrument [Line Items]	'	'
Unsecured senior notes, interest rate	6.88%	6.88%
Principal amount	450,000	450,000
2012 Senior Unsecured Notes	'	'
Debt Instrument [Line Items]	'	'
Unsecured senior notes, interest rate	6.38%	6.38%
Principal amount	350,000	200,000
Unamortized premium	2,960	'
Debt instrument, net	352,960	200,000
Exchangeable senior notes	'	'
Debt Instrument [Line Items]	'	'
Unsecured senior notes, interest rate	'	9.25%	[1]
Principal amount	'	11,000	[1]
Unamortized discount	'	-37
Debt instrument, net	'	10,963
Term loans	'	'
Debt Instrument [Line Items]	'	'
Interest rate	'Various	'Various
Debt instrument, net	$114,013	$114,197
[1]	The exchangeable senior notes were paid in full on April 1, 2013.

Debt_Principal_Payments_Due_fo

Debt - Principal Payments Due for Debt (Detail) (USD $)	Sep. 30, 2013
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]	'
2013	$64
2014	266
2015	45,283
2016	225,299
2017	320
Thereafter	812,781
Total	$1,084,013

Debt_Additional_Information_De

Debt - Additional Information (Detail) (USD $)

9 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

3 Months Ended

1 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2011

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Jun. 30, 2010

Oct. 31, 2011

Jun. 30, 2010

Sep. 30, 2013

Dec. 31, 2012

Mar. 09, 2012

Mar. 09, 2012

Mar. 09, 2012

Aug. 20, 2013

Feb. 17, 2012

Interest Rate Contract

Interest Rate Contract

Interest Rate Contract One

Interest Rate Contract Two

2006 Senior Unsecured Notes

2006 Senior Unsecured Notes

2006 Senior Unsecured Notes

2012 Term Loan

2012 Term Loan

2012 Term Loan

Senior Notes Six Point Three Seven Five Percent Due Two Thousand Twenty Two [Member]

Senior Notes Six Point Three Seven Five Percent Due Two Thousand Twenty Two [Member]

Revolving Credit Facility

Revolving Credit Facility

Minimum

Maximum

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unsecured senior notes, value of offering

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$150,000,000

$200,000,000

Net proceeds, after underwriting discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150,300,000

196,500,000

Unsecured senior notes, interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.38%

6.38%

Debt instrument redumption price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

102.00%

102.00%

Debt instrument yield to maturity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

6.00%

Debt instrument maturity date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15-Feb-20

15-Feb-20

Paid off term loan

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

'

'

Debt instrument face amount

'

'

'

'

'

'

'

'

'

125,000,000

125,000,000

70,000,000

'

'

'

'

Credit facilities, amount outstanding

'

'

'

'

'

'

'

'

'

'

'

'

330,000,000

400,000,000

'

'

Portion of debt instrument face amount

'

'

'

'

'

'

'

'

65,000,000

'

'

'

'

'

'

'

Fair value of the interest rate swaps

'

'

'

'

9,700,000

12,500,000

'

'

'

'

'

'

'

'

'

'

Interest rate of interest rate derivative instrument

'

'

'

'

'

'

5.51%

'

'

'

'

'

'

'

'

'

Maturity date of interest rate swap

'

'

'

'

'

'

'July 2016

'October 2016

'

'

'

'

'

'

'

'

Interest rate swap, amount fixed

'

'

'

'

'

'

'

60,000,000

'

'

'

'

'

'

'

'

Interest rate of derivative instrument

'

'

'

'

'

'

'

5.68%

'

'

'

'

'

'

'

'

Other assets, collateral

$4,700,000

'

'

$6,600,000

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of dividends which could be paid from adjusted operating funds

95.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of dividends which could be paid from operation funds

'

95.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum percentage of total unencumbered assets

'

150.00%

150.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Common_StockPartners_Capital_A

Common Stock/Partners' Capital - Additional Information (Detail) (USD $)	9 Months Ended			9 Months Ended		1 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2012	Aug. 20, 2013	Feb. 28, 2013	Feb. 07, 2012
				MPT Operating Partnership, L.P.	MPT Operating Partnership, L.P.	Public Offering	Public Offering	Public Offering
Class of Stock [Line Items]	'	'	'	'	'	'	'	'
Common stock, shares issued	160,880,000	'	136,335,000	'	'	11,500,000	12,650,000	23,575,000
Underwriters' purchase of shares pursuant to over allotment	'	'	'	'	'	1,500,000	1,650,000	3,075,000
Public offering price for common stock per share	'	'	'	'	'	$12.75	$14.25	$9.75
Proceeds from issuance of common stock	$313,319	$220,107	'	$313,319	$220,107	$140,400	$172,900	$220,100
Partnership units issued	'	'	'	24,150,000	23,575,000	'	'	'
Ownership interest in operating partnership	'	'	'	99.80%	'	'	'	'

Stock_Awards_Additional_Inform

Stock Awards - Additional Information (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Time-Based Awards	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share - based compensation ,shares issued	240,425	275,464
Stock awards vesting period in years	'3 years	'
Performance-Based Awards	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share - based compensation ,shares issued	204,255	252,566
Stock awards vesting period in years	'3 years	'
Multi-Year Performance-Based Awards	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share - based compensation ,shares issued	550,000	649,793
Stock awards vesting period in years	'3 years	'
Equity Incentive Plan	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Reserved shares of common stock for awards under the Equity Incentive Plan	7,395,132	'
Common stock remaining for future stock awards	495,132	'
Common stock remaining for future stock awards transferred to the equity incentive plan	7,395,132	'

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) (USD $)	Sep. 30, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Interest and rent receivables	$54,505		$45,289
Loans	331,612	[1]	334,693	[1]
Debt, net	-1,086,973		-1,025,160
Estimate of Fair Value, Fair Value Disclosure	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Interest and rent receivables	43,723		36,700
Loans	329,367	[1]	335,595	[1]
Debt, net	($1,116,389)		($1,082,333)
[1]	Excludes loans related to the Ernest Transaction since they are recorded at fair value and discussed below.

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments - Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis (Detail) (Fair Value Measurements, Recurring, USD $)	Sep. 30, 2013
In Thousands, unless otherwise specified
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	$201,583
Cost	201,583
Mortgage loans | Mortgage Loans	'
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	100,000
Cost	100,000
Acquisition Loan | Other loans	'
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	98,283
Cost	98,283
Equity investments | Other assets	'
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	3,300
Cost	$3,300

Fair_Value_of_Financial_Instru4

Fair Value of Financial Instruments - Additional information (Detail)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Adjustment for marketability discount	40.00%

Fair_Value_of_Financial_Instru5

Fair Value of Financial Instruments - Summary Showing Sensitivity Analysis by Using Basis Point Variations (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013
+100 basis points	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Estimated Increase (Decrease) In Fair Value of Financial Instruments	($300)
- 100 basis points	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$300

Discontinued_Operations_Discon

Discontinued Operations - Discontinued Operations (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Discontinued Operations And Disposal Groups [Abstract]	'	'	'	'
Revenues	$37	$460	$568	$5,919
Gain (loss) on sale	'	8,726	2,054	7,280
Income	$37	$8,643	$2,498	$11,050
Earnings per share/unit - diluted	'	$0.06	$0.02	$0.08

Earnings_Per_ShareCommon_Unit_1

Earnings Per Share/Common Unit - Calculation of Earnings Per Share (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]	'	'	'	'
Income from continuing operations	$25,666	$22,865	$76,819	$50,424
Non-controlling interests' share in continuing operations	-55	-44	-165	-130
Participating securities' share in earnings	-166	-225	-538	-715
Income from continuing operations, less participating securities' share in earnings	25,445	22,596	76,116	49,579
Income from discontinued operations attributable to MPT common stockholders	37	8,643	2,498	11,050
Net income, less participating securities' share in earnings	25,482	31,239	78,614	60,629
Basic weighted-average common shares	154,758	134,781	148,204	131,467
Dilutive potential common shares	1,211	1	1,313	'
Dilutive weighted-average common shares	155,969	134,782	149,517	131,467
MPT Operating Partnership, L.P.	'	'	'	'
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]	'	'	'	'
Income from continuing operations	25,666	22,865	76,819	50,424
Non-controlling interests' share in continuing operations	-55	-44	-165	-130
Participating securities' share in earnings	-166	-225	-538	-715
Income from continuing operations, less participating securities' share in earnings	25,445	22,596	76,116	49,579
Income from discontinued operations attributable to MPT common stockholders	37	8,643	2,498	11,050
Net income, less participating securities' share in earnings	$25,482	$31,239	$78,614	$60,629
Basic weighted-average common shares	154,758	134,781	148,204	131,467
Dilutive potential common shares	1,211	1	1,313	'
Dilutive weighted-average common shares	155,969	134,782	149,517	131,467

Earnings_Per_ShareCommon_Unit_2

Earnings Per Share/Common Unit - Additional Information (Detail) (Stock Options)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2012	Sep. 30, 2012
Stock Options	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Options excluded from earnings per share/unit	0.1	0.1

Commitments_and_Contingencies_

Commitments and Contingencies - Additional Information (Detail) (EUR €)	1 Months Ended		9 Months Ended	1 Months Ended	9 Months Ended	1 Months Ended	9 Months Ended	1 Months Ended	9 Months Ended
	Sep. 13, 2013	Jun. 11, 2013	Sep. 30, 2013	Jul. 18, 2013	Sep. 30, 2013	Jul. 18, 2013	Sep. 30, 2013	Sep. 13, 2013	Sep. 30, 2013
		Hospital		Maximum	Maximum	Minimum	Minimum	Rehabilitation Hospital	Rehabilitation Hospital
								Facility	Facility
Long-term Purchase Commitment [Line Items]	'	'	'	'	'	'	'	'	'
Number of facilities acquired	'	2	'	'	'	'	'	11	5
Business acquisition cost of acquired entity	€ 184	'	'	'	'	'	'	'	'
Percentage of rental rate increase	'	2.00%	9.00%	5.00%	2.00%	2.00%	0.50%	'	'
Financing for additional construction	€ 10	'	'	'	'	'	'	'	'
Business acquisition, Additional Commitment term	'2 years	'	'	'	'	'	'	'	'
Term of lease	'27 years	'10 years	'20 years	'	'	'	'	'	'
Percentage of annual rent increase	70.00%	'	'	'	'	'	'	'	'
Period past due, in days	'90 days	'	'	'	'	'	'	'	'

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail)	1 Months Ended	9 Months Ended		1 Months Ended
	Sep. 13, 2013	Sep. 30, 2013	Sep. 30, 2012	Oct. 16, 2013	Oct. 16, 2013	Oct. 10, 2013
		USD ($)	USD ($)	Subsequent Event	Subsequent Event	Subsequent Event
				USD ($)	Rehabilitation Hospital	Senior Notes Five Point Seven Five Percentage
						EUR (€)
Subsequent Event [Line Items]	'	'	'	'	'	'
Estimated total development cost	'	$9,400,000	'	$5,200,000	'	'
Public Offering principal amount	'	$313,319,000	$220,107,000	'	'	€ 200,000,000
Debt instrument interest rate	'	'	'	'	'	5.75%
Maturity date of note	'	'	'	'	'	10-Jan-20
Debt instrument interest payment terms	'	'	'	'	'	'Interest on the Notes will be payable semi-annually on April 1 and October 1 of each year, commencing on April 1, 2014
Debt instrument interest payment terms	'	'	'	'	'	'Semi-annually
Notes redemption term	'	'	'	'	'	'On or after October 1, 2016, we may redeem some or all of the Notes at a premium that will decrease over time. In addition, at any time and from time to time prior to October 1, 2016 the Issuers may redeem up to 35% of the aggregate principal amount of the Notes using the proceeds of one or more equity offerings.
Notes repurchase rate percentage on principal amount	'	'	'	'	'	101.00%
Period past due, in days	'90 days	'	'	'	'90 days	'

Condensed_Consolidating_Financ2

Condensed Consolidating Financial Information - Additional Information (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified			Restatement Adjustment [Member]	Restatement Adjustment [Member]	Restatement Adjustment [Member]	Restatement Adjustment [Member]	Restatement Adjustment [Member]	Restatement Adjustment [Member]
			Subsidiaries Guarantor	Subsidiaries Guarantor	Subsidiaries Non Guarantor	Subsidiaries Non Guarantor	Eliminations	Eliminations
Total Assets	$2,563,150	$2,178,886	$1,010,400	$888,900	$390,900	$5,500	($1,401,300)	($894,400)
Total liabilities	$1,204,581	$1,129,072	$1,010,400	$888,900	$390,900	$5,500	($1,401,300)	($894,400)

Condensed_Consolidating_Financ3

Condensed Consolidating Financial Information - Condensed Consolidated Balance Sheets (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	$1,606,432	$1,262,099	'	'
Real estate held for sale	'	16,497	'	'
Mortgage loans	368,650	368,650	'	'
Investment in direct financing leases	403,512	314,412	'	'
Gross investment in real estate assets	2,378,594	1,961,658	'	'
Accumulated depreciation and amortization	-150,666	-124,615	'	'
Net investment in real estate assets	2,227,928	1,837,043	'	'
Cash and cash equivalents	12,124	37,311	36,163	102,726
Interest and rent receivable	54,505	45,289	'	'
Straight-line rent receivable	44,240	35,860	'	'
Other loans	161,245	159,243	'	'
Other assets	63,108	64,140	'	'
Total Assets	2,563,150	2,178,886	'	'
Debt, net	1,086,973	1,025,160	'	'
Accounts payable and accrued expenses	73,852	65,961	'	'
Deferred revenue	23,229	20,609	'	'
Lease deposits and other obligations to tenants	20,527	17,342	'	'
Total liabilities	1,204,581	1,129,072	'	'
Total equity	1,358,569	1,049,814	'	'
Total Liabilities and Equity	2,563,150	2,178,886	'	'
Parent	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	'	'	'	'
Real estate held for sale	'	'	'	'
Mortgage loans	'	'	'	'
Investment in direct financing leases	'	'	'	'
Gross investment in real estate assets	'	'	'	'
Accumulated depreciation and amortization	'	'	'	'
Net investment in real estate assets	'	'	'	'
Cash and cash equivalents	'	'	'	'
Interest and rent receivable	'	'	'	'
Straight-line rent receivable	'	'	'	'
Other loans	'	'	'	'
Net intercompany receivable	32,053	27,393	'	'
Investment in subsidiaries	1,358,959	1,050,204	'	'
Total Assets	1,391,012	1,077,597	'	'
Accounts payable and accrued expenses	32,443	27,783	'	'
Net intercompany payable	'	'	'	'
Deferred revenue	'	'	'	'
Lease deposits and other obligations to tenants	'	'	'	'
Total liabilities	32,443	27,783	'	'
Total equity	1,358,569	1,049,814	'	'
Total Liabilities and Equity	1,391,012	1,077,597	'	'
Subsidiary Issuers	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	'	28	'	'
Mortgage loans	'	'	'	'
Investment in direct financing leases	'	'	'	'
Gross investment in real estate assets	'	28	'	'
Accumulated depreciation and amortization	'	'	'	'
Net investment in real estate assets	'	28	'	'
Cash and cash equivalents	11,391	35,483	34,371	101,230
Interest and rent receivable	715	212	'	'
Other loans	178	177	'	'
Net intercompany receivable	1,639,081	1,373,941	'	'
Investment in subsidiaries	783,441	647,029	'	'
Other assets	32,534	31,097	'	'
Total Assets	2,467,340	2,087,967	'	'
Debt, net	1,072,960	1,010,962	'	'
Accounts payable and accrued expenses	35,705	26,658	'	'
Deferred revenue	-284	143	'	'
Total liabilities	1,108,381	1,037,763	'	'
Total equity	1,358,959	1,050,204	'	'
Total Liabilities and Equity	2,467,340	2,087,967	'	'
Subsidiary Guarantors	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	1,259,234	1,196,124	'	'
Mortgage loans	268,650	268,650	'	'
Investment in direct financing leases	186,586	110,155	'	'
Gross investment in real estate assets	1,714,470	1,574,929	'	'
Accumulated depreciation and amortization	-142,939	-118,163	'	'
Net investment in real estate assets	1,571,531	1,456,766	'	'
Cash and cash equivalents	'	1,565	1,565	1,409
Interest and rent receivable	29,284	29,159	'	'
Straight-line rent receivable	36,051	29,314	'	'
Investment in subsidiaries	43,557	42,666	'	'
Other assets	980	1,522	'	'
Total Assets	1,681,403	1,560,992	'	'
Accounts payable and accrued expenses	4,935	10,492	'	'
Net intercompany payable	998,987	1,000,117	'	'
Deferred revenue	17,970	19,621	'	'
Lease deposits and other obligations to tenants	17,923	16,606	'	'
Total liabilities	1,039,815	1,046,836	'	'
Total equity	641,588	514,156	'	'
Total Liabilities and Equity	1,681,403	1,560,992	'	'
Non-Guarantor Subsidiaries	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	347,198	65,947	'	'
Real estate held for sale	'	16,497	'	'
Mortgage loans	100,000	100,000	'	'
Investment in direct financing leases	216,926	204,257	'	'
Gross investment in real estate assets	664,124	386,701	'	'
Accumulated depreciation and amortization	-7,727	-6,452	'	'
Net investment in real estate assets	656,397	380,249	'	'
Cash and cash equivalents	733	263	227	87
Interest and rent receivable	24,506	15,918	'	'
Straight-line rent receivable	8,189	6,546	'	'
Other loans	161,067	159,066	'	'
Other assets	29,594	31,521	'	'
Total Assets	880,486	593,563	'	'
Debt, net	14,013	14,198	'	'
Accounts payable and accrued expenses	769	1,028	'	'
Net intercompany payable	672,147	401,217	'	'
Deferred revenue	5,543	845	'	'
Lease deposits and other obligations to tenants	2,604	736	'	'
Total liabilities	695,076	418,024	'	'
Total equity	185,410	175,539	'	'
Total Liabilities and Equity	880,486	593,563	'	'
Eliminations	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	'	'	'	'
Real estate held for sale	'	'	'	'
Mortgage loans	'	'	'	'
Investment in direct financing leases	'	'	'	'
Gross investment in real estate assets	'	'	'	'
Accumulated depreciation and amortization	'	'	'	'
Net investment in real estate assets	'	'	'	'
Cash and cash equivalents	'	'	'	'
Interest and rent receivable	'	'	'	'
Straight-line rent receivable	'	'	'	'
Other loans	'	'	'	'
Net intercompany receivable	-1,671,134	-1,401,334	'	'
Investment in subsidiaries	-2,185,957	-1,739,899	'	'
Total Assets	-3,857,091	-3,141,233	'	'
Net intercompany payable	-1,671,134	-1,401,334	'	'
Total liabilities	-1,671,134	-1,401,334	'	'
Total equity	-2,185,957	-1,739,899	'	'
Total Liabilities and Equity	($3,857,091)	($3,141,233)	'	'

Condensed_Consolidating_Financ4

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Income (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues	'	'	'	'
Rent billed	$31,878	$30,298	$95,074	$90,680
Straight-line rent	2,853	2,745	8,260	5,429
Income from direct financing leases	11,298	5,773	29,284	12,979
Interest and fee income	14,427	14,037	43,282	33,486
Total revenues	60,456	52,853	175,900	142,574
Expenses	'	'	'	'
Real estate depreciation and amortization	8,789	8,308	26,051	24,826
Property-related	458	214	1,520	1,027
General and administrative	6,380	7,052	21,423	21,341
Acquisition expenses	4,179	410	6,457	4,115
Total operating expenses	19,806	15,984	55,451	51,309
Operating income (expense)	40,650	36,869	120,449	91,265
Other income (expense)	'	'	'	'
Other income (expense)	3	-23	-245	-55
Earnings from equity and other interests	843	1,065	2,511	1,944
Interest income (expense)	-15,830	-15,046	-45,896	-42,730
Net other expense	-14,984	-14,004	-43,630	-40,841
Income (loss) from continuing operations	25,666	22,865	76,819	50,424
Income (loss) from discontinued operations	37	8,643	2,498	11,050
Net income	25,703	31,508	79,317	61,474
Net income (loss) attributable to non-controlling interests	-55	-44	-165	-130
Net income attributable to MPT common stockholders	25,648	31,464	79,152	61,344
Parent	'	'	'	'
Other income (expense)	'	'	'	'
Equity in earnings of consolidated subsidiaries net of income taxes	25,703	31,508	79,317	61,474
Net income	25,703	31,508	79,317	61,474
Net income (loss) attributable to non-controlling interests	-55	-44	-165	-130
Net income attributable to MPT common stockholders	25,648	31,464	79,152	61,344
Subsidiary Issuers	'	'	'	'
Revenues	'	'	'	'
Interest and fee income	5,004	5,242	15,112	13,219
Total revenues	5,004	5,242	15,112	13,219
Expenses	'	'	'	'
Property-related	182	88	458	349
General and administrative	6,867	6,332	21,286	20,067
Acquisition expenses	4,179	410	6,457	4,115
Total operating expenses	11,228	6,830	28,201	24,531
Operating income (expense)	-6,224	-1,588	-13,089	-11,312
Other income (expense)	'	'	'	'
Other income (expense)	5	-21	-37	-49
Interest income (expense)	-16,055	-15,203	-46,298	-42,905
Net other expense	-16,050	-15,224	-46,335	-42,954
Income (loss) from continuing operations	-22,274	-16,812	-59,424	-54,266
Equity in earnings of consolidated subsidiaries net of income taxes	47,977	48,320	138,741	115,740
Net income	25,703	31,508	79,317	61,474
Net income (loss) attributable to non-controlling interests	-55	-44	-165	-130
Net income attributable to MPT common stockholders	25,648	31,464	79,152	61,344
Subsidiary Guarantors	'	'	'	'
Revenues	'	'	'	'
Rent billed	29,770	28,470	89,149	85,160
Straight-line rent	2,189	2,371	6,617	4,310
Income from direct financing leases	10,519	5,238	27,387	11,730
Interest and fee income	9,161	8,917	27,565	20,620
Total revenues	51,639	44,996	150,718	121,820
Expenses	'	'	'	'
Real estate depreciation and amortization	8,363	7,883	24,775	23,551
Property-related	251	116	792	580
Total operating expenses	8,614	7,999	25,567	24,131
Operating income (expense)	43,025	36,997	125,151	97,689
Other income (expense)	'	'	'	'
Other income (expense)	'	-2	'	-2
Earnings from equity and other interests	454	331	687	783
Interest income (expense)	454	388	1,083	867
Net other expense	908	717	1,770	1,648
Income (loss) from continuing operations	43,933	37,714	126,921	99,337
Income (loss) from discontinued operations	'	314	-4	106
Equity in earnings of consolidated subsidiaries net of income taxes	1,114	1,129	3,356	3,367
Net income	45,047	39,157	130,273	102,810
Net income attributable to MPT common stockholders	45,047	39,157	130,273	102,810
Non-Guarantor Subsidiaries	'	'	'	'
Revenues	'	'	'	'
Rent billed	5,403	4,163	14,970	12,446
Straight-line rent	664	374	1,643	1,119
Income from direct financing leases	5,750	5,394	16,744	12,600
Interest and fee income	7,299	6,943	21,816	17,358
Total revenues	19,116	16,874	55,173	43,523
Expenses	'	'	'	'
Real estate depreciation and amortization	426	425	1,276	1,275
Property-related	8,291	7,204	24,162	18,375
General and administrative	-487	720	137	1,274
Total operating expenses	8,230	8,349	25,575	20,924
Operating income (expense)	10,886	8,525	29,598	22,599
Other income (expense)	'	'	'	'
Other income (expense)	-2	'	-208	-4
Earnings from equity and other interests	389	734	1,824	1,161
Interest income (expense)	-7,266	-7,296	-21,892	-18,403
Net other expense	-6,879	-6,562	-20,276	-17,246
Income (loss) from continuing operations	4,007	1,963	9,322	5,353
Income (loss) from discontinued operations	37	8,329	2,502	10,944
Net income	4,044	10,292	11,824	16,297
Net income attributable to MPT common stockholders	4,044	10,292	11,824	16,297
Eliminations	'	'	'	'
Revenues	'	'	'	'
Rent billed	-3,295	-2,335	-9,045	-6,926
Income from direct financing leases	-4,971	-4,859	-14,847	-11,351
Interest and fee income	-7,037	-7,065	-21,211	-17,711
Total revenues	-15,303	-14,259	-45,103	-35,988
Expenses	'	'	'	'
Property-related	-8,266	-7,194	-23,892	-18,277
Total operating expenses	-8,266	-7,194	-23,892	-18,277
Operating income (expense)	-7,037	-7,065	-21,211	-17,711
Other income (expense)	'	'	'	'
Interest income (expense)	7,037	7,065	21,211	17,711
Net other expense	7,037	7,065	21,211	17,711
Equity in earnings of consolidated subsidiaries net of income taxes	-74,794	-80,957	-221,414	-180,581
Net income	-74,794	-80,957	-221,414	-180,581
Net income (loss) attributable to non-controlling interests	55	44	165	130
Net income attributable to MPT common stockholders	($74,739)	($80,913)	($221,249)	($180,451)

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Comprehensive Income - Condensed Consolidated Statements of Comprehensive Income (Loss) (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Comprehensive Income (Loss) [Line Items]	'	'	'	'
Net income	$25,703	$31,508	$79,317	$61,474
Other comprehensive income (loss):	'	'	'	'
Unrealized gain (loss) on interest rate swap	182	-443	2,788	-989
Total comprehensive income	25,885	31,065	82,105	60,485
Comprehensive income attributable to non-controlling interests	-55	-44	-165	-130
Comprehensive income attributable to MPT common stockholders	25,830	31,021	81,940	60,355
Parent	'	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'	'
Net income	25,703	31,508	79,317	61,474
Other comprehensive income (loss):	'	'	'	'
Unrealized gain (loss) on interest rate swap	182	-443	2,788	-989
Total comprehensive income	25,885	31,065	82,105	60,485
Comprehensive income attributable to non-controlling interests	-55	-44	-165	-130
Comprehensive income attributable to MPT common stockholders	25,830	31,021	81,940	60,355
Subsidiary Issuers	'	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'	'
Net income	25,703	31,508	79,317	61,474
Other comprehensive income (loss):	'	'	'	'
Unrealized gain (loss) on interest rate swap	182	-443	2,788	-989
Total comprehensive income	25,885	31,065	82,105	60,485
Comprehensive income attributable to non-controlling interests	-55	-44	-165	-130
Comprehensive income attributable to MPT common stockholders	25,830	31,021	81,940	60,355
Subsidiary Guarantors	'	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'	'
Net income	45,047	39,157	130,273	102,810
Other comprehensive income (loss):	'	'	'	'
Total comprehensive income	45,047	39,157	130,273	102,810
Comprehensive income attributable to MPT common stockholders	45,047	39,157	130,273	102,810
Non-Guarantor Subsidiaries	'	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'	'
Net income	4,044	10,292	11,824	16,297
Other comprehensive income (loss):	'	'	'	'
Total comprehensive income	4,044	10,292	11,824	16,297
Comprehensive income attributable to MPT common stockholders	4,044	10,292	11,824	16,297
Eliminations	'	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'	'
Net income	-74,794	-80,957	-221,414	-180,581
Other comprehensive income (loss):	'	'	'	'
Unrealized gain (loss) on interest rate swap	-182	443	-2,788	989
Total comprehensive income	-74,976	-80,514	-224,202	-179,592
Comprehensive income attributable to non-controlling interests	55	44	165	130
Comprehensive income attributable to MPT common stockholders	($74,921)	($80,470)	($224,037)	($179,462)

Condensed_Consolidating_Financ5

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Cash Flows (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating Activities	'	'
Net cash provided by (used in) operating activities	$101,564	$74,709
Investing activities	'	'
Cash paid for acquisitions and other related investments	-371,500	-606,500
Principal received on loans receivable	4,694	9,507
Net proceeds from sale of real estate	18,409	'
Net proceeds from sale of real estate	18,409	34,100
Investments in loans receivable	-1,445	-1,293
Construction in progress and other	-63,422	-35,920
Net cash provided by (used in) investing activities	-413,264	-600,106
Financing Activities	'	'
Revolving credit facilities, net	-80,000	35,400
Additions to term debt	153,000	300,000
Payments of term debt	-11,185	-171
Distributions paid	-87,928	-76,770
Proceeds from sale of common shares/units, net of offering costs	313,319	220,107
Lease deposits and other obligations to tenants	3,589	-13,391
Debt issuance costs paid and other financing activities	-4,282	-6,341
Net cash provided by (used in) financing activities	286,513	458,834
Increase (decrease) in cash and cash equivalents for period	-25,187	-66,563
Cash and cash equivalents at beginning of period	37,311	102,726
Cash and cash equivalents at end of period	12,124	36,163
Parent	'	'
Operating Activities	'	'
Net cash provided by (used in) operating activities	91	16
Investing activities	'	'
Investments in and advances to subsidiaries	-225,683	-143,554
Net cash provided by (used in) investing activities	-225,683	-143,554
Financing Activities	'	'
Distributions paid	-87,727	-76,569
Proceeds from sale of common shares/units, net of offering costs	313,319	220,107
Net cash provided by (used in) financing activities	225,592	143,538
Cash and cash equivalents at beginning of period	'	'
Cash and cash equivalents at end of period	'	'
Subsidiary Issuers	'	'
Operating Activities	'	'
Net cash provided by (used in) operating activities	-38,891	-38,780
Investing activities	'	'
Investments in and advances to subsidiaries	-267,545	-540,016
Construction in progress and other	-765	-59
Net cash provided by (used in) investing activities	-268,310	-540,075
Financing Activities	'	'
Revolving credit facilities, net	-80,000	75,000
Additions to term debt	153,000	300,000
Payments of term debt	-11,000	'
Distributions paid	-87,928	-76,770
Proceeds from sale of common shares/units, net of offering costs	313,319	220,107
Debt issuance costs paid and other financing activities	-4,282	-6,341
Net cash provided by (used in) financing activities	283,109	511,996
Increase (decrease) in cash and cash equivalents for period	-24,092	-66,859
Cash and cash equivalents at beginning of period	35,483	101,230
Cash and cash equivalents at end of period	11,391	34,371
Subsidiary Guarantors	'	'
Operating Activities	'	'
Net cash provided by (used in) operating activities	156,913	109,018
Investing activities	'	'
Cash paid for acquisitions and other related investments	-95,000	-410,000
Principal received on loans receivable	'	5,491
Net proceeds from sale of real estate	'	800
Investments in and advances to subsidiaries	-1,506	380,605
Construction in progress and other	-63,691	-33,869
Net cash provided by (used in) investing activities	-160,197	-56,973
Financing Activities	'	'
Revolving credit facilities, net	'	-39,600
Lease deposits and other obligations to tenants	1,719	-12,289
Net cash provided by (used in) financing activities	1,719	-51,889
Increase (decrease) in cash and cash equivalents for period	-1,565	156
Cash and cash equivalents at beginning of period	1,565	1,409
Cash and cash equivalents at end of period	'	1,565
Non-Guarantor Subsidiaries	'	'
Operating Activities	'	'
Net cash provided by (used in) operating activities	-16,549	4,455
Investing activities	'	'
Cash paid for acquisitions and other related investments	-276,500	-196,500
Principal received on loans receivable	4,694	4,016
Net proceeds from sale of real estate	18,409	'
Net proceeds from sale of real estate	'	33,300
Investments in and advances to subsidiaries	269,142	159,427
Investments in loans receivable	-1,445	-1,293
Construction in progress and other	1,034	-1,992
Net cash provided by (used in) investing activities	15,334	-3,042
Financing Activities	'	'
Payments of term debt	-185	-171
Lease deposits and other obligations to tenants	1,870	-1,102
Net cash provided by (used in) financing activities	1,685	-1,273
Increase (decrease) in cash and cash equivalents for period	470	140
Cash and cash equivalents at beginning of period	263	87
Cash and cash equivalents at end of period	733	227
Eliminations	'	'
Investing activities	'	'
Investments in and advances to subsidiaries	225,592	143,538
Net cash provided by (used in) investing activities	225,592	143,538
Financing Activities	'	'
Distributions paid	87,727	76,569
Proceeds from sale of common shares/units, net of offering costs	-313,319	-220,107
Net cash provided by (used in) financing activities	-225,592	-143,538
Cash and cash equivalents at beginning of period	'	'
Cash and cash equivalents at end of period	'	'